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Micro- and nano-scale silica materials have recently gained attention due to their 
potential as biosensors, site-specific drug delivery systems and diagnostic tools.  
 
Accordingly, examples of the preparation and use of silica materials for such applications 
are highlighted throughout this dissertation. 
A significant portion of developing materials used for targeting, detection, or sensing 
applications is functionalizing the surface of the material with biomolecules (i.e. proteins, 
nucleotides, carbohydrates) that function as targeting or receptor moieties.  N-linked 
pentenyl glycoside derivatives, prepared via a modified Staudinger ligation method, 
proved to be key intermediates in developing a methodology to efficiently prepare 
carbohydrate derivatives capable of functionalizing a variety of different materials.  
Glucosyl and lactosyl siloxane derivatives, synthesized from the hydrosilation of the 
corresponding pentenyl glycoside intermediate, were used to prepare glucose- and 
lactose-functionalized evanescent wave fiber Bragg gratings. The carbohydrate-
functionalized fibers were subsequently used to detect the specific binding of lectins to 
the carbohydrates attached to the surface of the fiber, demonstrating their potential as 
biosensors.  In addition, olefin cross metathesis was used to couple N-linked pentenyl 
glycoside intermediates with terminal alkene derivatives containing moieties used to 
functionalize a range of inorganic material, thus yielding glycoconjugates capable of 
functionalizing material of various composition. The advantage of this synthetic strategy 
is the ability to create a series of carbohydrate derivatives capable of functionalizing a 
variety of different material from a common N-linked pentenyl glycoside intermediate. 
 Mesoporous silica nanoparticles (MSN) have potential as drug delivery and 
controlled release devices due to their high surface area and large payload capacity. The 
effect of surface charge and pH on the release of the fluorescent dye rhodamine 6G from 
MSN prepared via an aerosol methodology has been studied.  Release profiles of 
rhodamine 6G from bare and amine-coated MSN at pH 5.0 and 7.4 are very different and 
demonstrate that electrostatic interactions between entrapped rhodamine 6G molecules 
and the charged surface of the MSN have a significant effect on release kinetics.  Release 
of rhodamine 6G from amine-coated MSN can be fit to a single exponential function, 
while release from bare MSN can be fit to a double exponential function—indicating that 
the release of rhodamine 6G from bare MSN is a two-phase process.  In addition, it was 
determined that MSN need to be sonicated in dye solution to maximize their loading 
capacity. 
 Fluorescent silica nanoparticles (FSN) are being studied for their potential in 
diagnostic imaging techniques and immunoassays. Fluorescent silica nanoparticles were 
prepared by incorporating a hydrophobically modified dye into a mesoporous silica 
nanoparticle synthesis procedure.  The MSN-based FSN do not leach dye and have 
strong, stable fluorescence that is 5 times more intense than that of CdSe quantum dots.  
For diagnostic applications, a method to selectively and covalently bind antibodies to the 
surface of the FSN was devised.  It was found that the triblock copolymer, Pluronic F127, 
is effective in preventing nonspecific binding of proteins to FSN.  Antibodies were 
selectively and covalently attached to FSN that were functionalized with a mixed 
PEG/epoxide coating in the presence of Pluronic F127. 
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 Recently, micro- and nano-scale inorganic materials functionalized with proteins 
and carbohydrates have gained much attention due to their potential as biosensors and 
diagnostic tools, site-specific drug delivery systems, and vaccines.
1-4 
 In addition, these 
hybrid materials (known as microarrays and functionalized nanoparticles) have also been 
used to study and gain a better understanding of biological processes, such as specific 
carbohydrate-protein binding, carbohydrate antigen adhesion, and carbohydrate-
carbohydrate interactions.
1-2  
This chapter will review the methodologies used to prepare 
carbohydrate- and protein-functionalized materials found throughout the literature and 
highlight the work that has been done within the DeShong lab to prepare carbohydrate-
functionalized materials.   
 
1.1 Surface Functionalization 
In the early to mid twentieth century, Blodgett
5-6
 and then Bigelow
7
 demonstrated 
that organic monolayers could be formed on solid surfaces.  Since their initial 
discoveries, the formation of organic films on solid surfaces has grown into a significant 
area of research.  Throughout the literature, one will find numerous examples of 
siloxanes, organophosphonates, and carboxylic acids immobilized on hydroxalated 
surfaces and metal oxides, as well as organothiols absorbed onto gold and silver.
8-29
  
Notable is the work done by Whitesides, Nuzzo, and Allara that has greatly contributed to 
 2 
the understanding and characterization of self-assembled monolayers of organothiols 
absorbed onto gold surfaces.
10-13 
 In addition, Lee, Zisman, and Sagiv conducted seminal 
research investigating the formation of silane films on glass surfaces using siloxanes and 
chlorosilanes.
9, 14-17
  Others have built upon their work and have made significant 
progress in developing and understanding silane SAMs.
9
  Accounts by Allara, Nuzzo and 
Ogawa describe n-alkanoic acids forming monolayers on aluminum oxide.
 9, 23-24
 The 
formation of n-alkanoic acids on silver surfaces was also reported by Schlotter et al.
9, 25
, 
while Tao and coworkers have studied and characterized n-alkanoic acid SAMs on 
copper and other metal oxides.
9, 26
   Table 1 lists different materials and the functional 
groups that are commonly used to functionalize them. 
 
Table 1 :  List of materials and the functional groups used to functionalize their surface.  























































Figure 1:  Schematic representation of monolayer formation of (A) thiols on gold, (B) 

































The principles of surface functionalization are used to prepare nucleotide-, 
protein-, and carbohydrate-functionalized materials.  It is appreciated that biomolecule-
functionalized nanoparticles have been prepared by passive (non-covalent) absorption, 
such as ionic bonding and electrostatic absorption.
 3, 30
 However, these systems are not as 
robust and reproducible as systems created through covalent linkages.
30
  Biomolecules 
passively absorbed onto a surface can fall off, denature, and lose their biological 
activity.
3, 30
   By covalently linking biomolecules to the surface, these issues of instability 
are bypassed.
 30
  Thus, significant research has been done to develop methodologies for 
specific, covalent attachment of proteins and carbohydrates to solid surfaces.
 3-4, 31-32 
 
These surface functionalization methodologies will be highlighted in the next two 
sections of this chapter. 
 4 
1.2 Protein-Functionalized Materials 
Many strategies that are used to prepare protein-functionalized materials are 
predicated on the use of bifunctional “linker” molecules, where one functional group is 
used to make a covalent bond to a protein or carbohydrate and the other functional group 
is used to anchor the complex to a surface of interest (Figure 2).
4
  The bifunctional linker 
molecule can first be attached to a surface and then the protein or carbohydrate can react 
to form a covalent bond with the functionalized surface, or the bifunctional linker can 
first be reacted with a protein or carbohydrate to produce protein derivatives and 
glycoconjugates containing a terminal functional group that can then be covalently 
attached to the desired material.  The composition of the material being functionalized 
dictates what functional group is used as the anchor moiety.  As highlighted above, thiols 
and disulfides are used to immobilized molecules to the surface of gold and silver, while 
siloxanes and organophosphonates are used to functionalize silica and other hydroxylated 
surfaces.  The functional group used to couple the protein to the bifunctional linker or to 
a functionalized surface is dependent upon the protein conjugation methodology that is 






























Most protein coupling methodologies utilize chemistry common to functional 
groups found within the native protein, such as amines, thiols and carboxylic acids.  
Lysine and cysteine residues found within the protein are commonly used to conjugate 











 surfaces (Figure 3, A-E).  However, others have demonstrated that 
peptides and proteins can be immobilized onto surfaces modified with photoactivatable 
groups.  Angeloni and co-workers prepared glass slides with a dextran polymer 
derivatized with aryltrifluoromethyl-diazirine groups.
45
  Upon exposure to ultraviolet 
light (350 nm) the aryltrifluoromethyl-diazirine groups decompose to generate molecular 
nitrogen and highly reactive carbenes.  The carbenes then undergo insertion reactions 
with proteins, covalently linking the protein or peptide to the surface (Figure 3, F).
45 
 
Similairly, irradiating surfaces functionalized with arylazides, and benzophenone 
derivatives result in the formation of nitrene and ketyl radical intermediates that can 




Others have prepared protein derivatives that contain a terminal functionality 
designed to react specifically with a complementary moiety immobilized unto a surface 
(Figure 3, F-G).  For example, Maltzahn et al prepared peptides bearing heptynoic acid or 
parpargylglycine at the N-terminus.
47
  The terminal alkynes of the peptide derivatives 
were then coupled to azides exposed on the surface of iron oxide nanoparticles via 
“click” chemistry.
47 
 Additionally, Houseman and coworkers utilize the Diels-Alder 
reaction to couple peptide-cyclopentadiene derivatives with quinone groups that are 




















































































1.3 Carbohydrate-Functionalized Materials 
Carbohydrates are not as chemically diverse as proteins, so there are only a few 
methods known to attach unmodified carbohydrates to functionalized surfaces.  A 
common strategy employed to create glycan arrays from unmodified carbohydrates 
entails reacting a reducing sugar with surfaces functionalized with hydrazide or 
alkylaminooxy groups (Figure 4).
49-54
  For example, Zhi et al. prepared oligosaccharide 
microarrays by coupling nonderivatized oligosaccharides to hydrazine modified gold 
films.
50
  More recently, Bertozzi reported conjugating a range of reducing sugars to a 
poly(acryloyl hydrazide) scaffold in the presence of aniline.
49
  Alternatively, in the same 
way they attached proteins to photoactivatable surfaces, Angeloni et al. prepared glycan 
microarrays by covalently attaching bacterial exopolysaccharides to carbenes generated 


























Carbohydrate-functionalized materials are typically prepared from 
glycoconjugates containing a terminal functional group that can be covalently attached to 
the surface of the material.  These glycoconjugates are prepared using standard 
glycosylation strategies.
55-56
  Penades et al employed the trichloroacetimidate method to 
produce a series of carbohydrate derivatives bearing a terminal thiol at the anomeric 
carbon (Figure 5, A).
57
  Nishimura et al used the same approach to develop a novel solid 
phase oligosaccharide synthesis technique using gold nanoparticles.
58
  Using the 
traditional Koenigs-Knorr method, Lin and coworkers also prepared thiol terminated 
glycoconjugates by glycosylating carbohydrate-bromide derivatives using 4-pentenyl 
alcohol (Figure 5, B).
59
  The alkene-terminated glycoconjugates were then converted into 
thiol conjugates via radical elongation methods.
 59
   Additionally, Kamerling et al 
describe a reductive amination procedure that expediently introduces a thiol-containing 
spacer at the reducing end of a free oligosaccharide (Figure 5, C) .
60





synthesized azide-containing sugars that were subsequently attached to the 
surface of nanoparticles functionalized with alkynes via “click” chemistry.  Wang utilized 
the trichloroacetimidate method to create the azide derivatives, while Huang used a 
Lewis acid promoted glycosylation method (Figure 5, D).   Huang also synthesized 
carbohydrate amido-acid derivatives that were then coupled to amine groups present at 
the surface of silica-coated magnetite nanoparticles.
62
  In addition, Ying et al prepared 
dextran derivatives containing succinimidyl-activated esters, which were then conjugated 












































































































Our lab previously reported the formation of glycosylamide derivatives from 
glycopyranosyl azides via a modified Staudinger ligation method (Figure 6).
64-65
  Using 
this methodology, several disulfide containing carbohydrate derivatives were synthesized 
and used to functionalize gold surfaces and nanoparticles.
65 
 This synthetic strategy is 
superior to other methods because it is possible to control the stereochemistry at the 
anomeric center by choosing the “appropriate combination of phosphine and reaction 
conditions”.
65
  The ability to control the stereochemistry at the anomeric center is 
significant because the two different anomers form monolayers on gold with different 
surface characteristics.
65 
 X-Ray photoelectron spectroscopy was used to determine that 
!-linked glucopyranosylamide derivatives form monolayers with higher surface coverage 
 11 
than the corresponding !-linked derivatives.  In addition, the glycosylamide derivatives 
are quite robust.  The amide linkage can withstand strongly acidic or basic conditions, 
which enables a wide range of protecting group strategies to be employed if needed in 
later chemical transformations.
65
   
 
 



































2 Results and Discussion 
2.1 Preparation of Carbohydrate-Siloxane Derivatives via Hydrosilation  
 Silica materials have gained considerable attention in the biotechnology 
community due in large part to their biocompatibility and ease of preparation.
 66
  The 
preparation of silica biosensors, diagnostic tools and site-specific drug delivery systems 
requires a need to prepare carbohydrate- and protein-functionalized silica materials in an 
efficient manner.  Thus, the goal of the research presented here was to extend our 
glycosylation methodology to the preparation of glycoconjugates containing terminal 
siloxanes that could then be immobilized onto silica surfaces. 
In our synthetic strategy, we coupled glucopyranosyl azide 1  with 4-pentenioc 
acid to yield the glucose-alkene derivative 2 .  Hydrosilation of the terminal alkene using 
platinum (IV) oxide yielded the desired terminal-siloxane conjugate 3 (Figure 7).  
 12 
Unfortunately, this methodology is limited by the competing hydrogenation reaction that 
gives the fully saturated pentanyl derivative 4 .  Nevertheless, the same hydrosilation 
method was also employed to prepare lactose- and mannose-siloxane conjugates 6 and 
11 , respectively.  Table 1 summarizes the results of these hydrosilation reactions.  It is 
important to note that lactose-alkene 5  was prepared using the same coupling 
methodology as glucose-alkene 2 .  However, because only the !-form of mannose-azide 
8  was produced in the azidination step, a different coupling strategy, which was 
previously reported by our lab, was needed to create the "-mannose-alkene 10 .
64
  In this 
coupling strategy, the stereochemistry at the anomeric carbon is set by the formation of 
the isoxazoline intermediate 9 , which is formed in situ (Figure 8).    
 








































3: R = Si(OEt)3















































Table 2 :  Hydrosilation results. 
Entry Starting Carbohydrate-Alkene Hydrosilation Product Hydrogenation Product
Siloxane : Alkane 
Ratio (mol)1



































































































Proof that carbohydrate-siloxane conjugates could be used to functionalize silica 
surfaces was acquired through X-ray photoelectron spectroscopy (XSP).  Glucose-
siloxane 3  was immobilized onto a glass cover slip and the functionalized slide was then 
analyzed using XPS. .  The high-resolution X-ray photoelectron spectra for bare and 
functionalized glass slides are depicted in Figure 9.   The C 1s spectrum of the 
 14 
unfunctionalized glass slide indicates a small amount of carbon on the surface due to 
hydrocarbon contamination, with some oxidized carbon due to atmospheric exposure.  
Notably, there is no nitrogen detected on the surface of the bare, unfunctionalized glass 
slide.  However, the XPS spectrum of the glass slide that was treated with glucose-
siloxane 1  reveals a well-resolved nitrogen peak at 400.2 eV (~2 atomic % of all 
elements detected) and increased oxidized carbon species (C=O, C-N, and C-O), which is 
consistent with the attachment of the protected glucose-siloxane conjugate 
 
Figure 9 :  C 1s and N 1s high-resolution X-ray photoelectron spectra of the bare, 




Legend:  1 = C-C/C-H, 2 = C-O / C-N, 3 =  RC=ON, 4 = OC=OR 
 
 Additional confirmation that the carbohydrate-siloxane can be immobilized onto 
silica surfaces came from studies performed in the Dagenais lab in the Department of 
 15 
Electrical and Computer Engineering at the University of Maryland, College Park.  
Dagenais et al. used the glucose- and lactose-siloxane derivatives (compound 3  and 4) to 
create carbohydrate-functionalized evanescent wave fiber Bragg gratings.
67
  The fibers 
used are composed of hydrogen-loaded germanosilicate and were etched to a final 
diameter of 5 !m.  Dagenais and coworkers monitored the attachment of glucosyl 
siloxane, 3 , to the fiber Bragg grating by measuring the change in the Bragg wavelength 
over time.  The evanescent wave in the fiber sensor senses the change of the index of 
refraction following the binding of the carbohydrate to the surface of the sensor.  This 
change of index of refraction leads to a change of the Bragg wavelength, which is 
detected.
67
   A final shift of 24 pm was measured after the fiber was incubated in a 
solution of 3  for one hour.  This change in Bragg wavelength corresponds to a change of 
the surrounding index of 5.6 x 10
-4
.  If it is assumed that a solid layer of glucose is 
formed on the fiber of index 1.543, a beam propagation simulation suggests that a layer 
with a thickness of 1 nm is formed, corresponding to a monolayer of glucose conjugate 
3 .
67
    
 Dagenais and coworkers also provided proof that the surface-immobilized 
carbohydrate-siloxane conjugates are functional and can be used for sensing applications.  
Using the same method of detection described above, Ryu was able to detect the specific 
binding of lectins to carbohydrate-functionalized fibers.
68
  The preparation of unprotected 
glucose-functionalized fibers is outlined in Figure 10.  Lactose-functionalized fibers were 
prepared in an analogous fashion using lactose-siloxane 4 .  The acetylated carbohydrate-
siloxane conjugates were first immobilized onto the Bragg fiber, and then 0.2M sodium 
ethoxide solution was used to remove the acetate protecting groups.  The functionalized 
 16 
fibers were then exposed to separate solutions of concanavalin A (Con A) and peanut 
agglutinin (PNA).  Con A is known to bind selectively to glucose and mannose, while 
PNA is known to be selective for galactose.  Exposure of Con A to glucose-
functionalized fibers resulted in a Bragg wavelength shift of 60 pm.  However, no shift of 
the Bragg wavelength was observed when the glucose-functionalize fiber was exposed to 
PNA.
68
  Conversely, exposing the lactose-functionalized fiber to PNA caused a shift of 
40 pm, while exposing the lactose-functionalized fiber to Con A had no effect on the 
Bragg wavelength.
68
  These results demonstrate that the carbohydrates bound to the 
surface of the fibers are functional and that carbohydrate functionalized Bragg fiber 
gratings can be used to detect the selective binding of lectins to the immobilized 
carbohydrates.     
 










































2.2 Preparation of Carbohydrate Derivatives via Grubbs’ Cross-Metathesis  
While developing the hydrosilation methodology, it was realized that the pentenyl 
glycoside intermediates (2 , 5 , and 10) had the potential to be quite valuable.  Fraser-Reid 
et al have reported the preparation of O-linked pentenyl glycosides and a number of 
transformations that they can undergo.
69
  In addition, olefin cross-metathesis (CM) using 
Grubbs’ ruthenium-based carbene catalysts  has emerged as a convenient and popular 
method to functionalize terminal alkenes (Figures 11-12).
69-78
  Importantly, there are 
numerous examples in which cross-metathesis has been utilized to couple O- and C-
linked alkenyl glycosides with other terminal olefins to produce a variety of 
glycoconjugates.
79-89
  For example, Danishefsky et al demonstrated that !-O-pentenyl-
glycosides undergo olefin cross-metathesis with amino acid derivatives containing a 
terminal alkene to yield glycoprotein conjugates.
89
  Having stable, alkene-terminated 
glycoconjugates readily available, we recognized that olefin cross metathesis could be 
used as a general, practical approach to glycoconjugates with a variety of terminal 
functionalities that could be used to prepare glycoconjugate functionalized materials..   
 










































At the onset of this project, a series of commercially available cross-coupling 
partners were selected that could be used to functionalize a variety of surfaces, and would 
create monolayers with beneficial features (Figure 13).  We were most interested in 
vinyltriethoxysiloxane, alkenyl thioesters, allylic alcohol derivatives, and methyl acrylate.  
Cross-coupling products obtained from using vinyltriethoxysiloxane could be used to 
functionalize silica surfaces, while products formed using alkenyl thioesters could easily 
be transformed into thiol derivatives for functionalizing gold materials.  Allylic alcohols 
were of interest because they could be used to model allylic polyethylene glycol (PEG) 
units.  PEG moieties are often used to form hybrid monolayers on nanoparticles due to 
their ability to prevent nanoparticle aggregation in aqueous media.
90
  PEG groups have 
also been shown to prevent nonselective binding in biological screening assays.
91
  
Finally, methyl acrylate was chosen because the corresponding products can be converted 
























Using Grubbs’ ruthenium-based, N-heterocyclic carbene-coordinated catalyst A , 
we were able to link cross coupling partners with glucosyl alkene 2  and lactosyl alkene 5  
with varying success (Figure 14).  Table 3 documents the results of these metathesis 
reactions. 
 










































































Coupling Partner Catalyst Mol % Cross Metathesis Product % Yield E/Z Ratio1



































































            
1
E/Z ratios were determined by 
1
H NMR. 




The carbohydrate-alkene conjugates reacted most efficiently with methyl acrylate 
I and vinyltriethoxysilane II, respectively. This was expected based on the work of 
others.
78
  It is known that electron-deficient, sterically hindered alkenes, such as acyrlates 
and vinyl siloxanes, are good cross-coupling candidates.
70, 78
  These types of alkenes do 
not readily homodimerize, and the products formed do not readily undergo secondary 
metathesis reactions.
78
  The yields for products 13  and 14  are consistent with similar 
systems reported by Bruchner in which C-allyl-glycosides are coupled to !,"-unsaturated 
amide compounds using catalyst A .
87
  However, the authors report a 25% increase in 
yield using Hoveyda-Grubbs’ second-generation metathesis catalyst, B .
87
  Thus, it may 
 21 
be of interest to retry the metathesis between our glycoconjugates and couplings partners 
I and II using catalyst B . 
The inefficiency of the cross metathesis reactions using octenyl thioester III and 
the allylic ether IV  can be attributed to the propensity of the coupling partners and the 
alkene-glycoconjugates to homodimerize.  It is well established that electron-rich, 
sterically unhindered alkenes readily homodimerize.
78
  Metathesis between two alkenes 
that have the tendency to homodimerize will result in a statistical distribution of 
homodimerized products and the desired cross-coupled product.
78
  However, it has been 
shown that the efficiency of cross-metathesis between glycosyl-alkenes and coupling 
partners that readily homodimerize can be increased by placing a methyl “cap” on the 
coupling partner
89




The E-isomer of the cross metathesis products was favored in all of the metathesis 
reactions reported here, which is consistent with the findings of others.
70, 72, 78, 88
  The 
stereoselective formation of the E-isomer is important for our purposes, because it is 
known that monolayers formed from Z-alkenes have different characteristics than 
monolayers formed using the trans-isomer.  For example, E-unsaturated fatty acids form 
monolayers that are packed more densely than monolayers formed from the 
corresponding Z-isomer.
92
  Thus, the properties of the monolayers formed using the 
metathesis products may be affected by their E/Z ratio.  Notably, Wong has reported that 
perbenzylated allyl glycosides undergo metathesis with non-functionalized alkenes to 




2.3 Attachment of Reducing Sugars to Amine-Functionalized Surfaces via Reductive 
Amination 
 Though the Staudinger ligation and olefin cross metathesis methodologies were 
effective in the preparation of simple glycan derivatives, extending these methodologies 
to the synthesis of complex oligosaccharides was a concern due to foreseen difficulty 
with substrate solubility and the complex protecting group strategies that would be 
required.  Thus, a method that could be used to directly immobilize natural, unprotected 
oligosaccharides to a surface was sought.  As mentioned above, others have 
accomplished this goal by coupling reducing sugars to surfaces decorated with hydrazine 
derivatives.  However, preparing a hydrazine-functionalized surface is a multistep 
process. Conversely, aminated surfaces can be achieved in one step using commercially 
available amine-thiols or amino-siloxane compounds.  In addition, it is well known that 
reductive amination is a facile method used to conjugate reducing carbohydrates with 
proteins.  Thus, we rationalized that coupling natural, unmodified carbohydrates to 
amine-coated surfaces could be achieved through reductive amination.   
 In the following studies, fluorescent silica nanoparticles (FSN) were used.  Refer 
to chapter 3 of this dissertation for details in regard to the preparation and 
characterization of these materials.  Amine-coated fluorescent silica nanoparticles were 
prepared by reacting bare FSN with 3-aminopropyltriethoxysilane (APTES).  Initially, an 
attempt to conjugate lactose to APTES-functionalized FSN under standard reductive 
amination conditions using NaCNBH3 in acetate buffer (pH = 5.0) was made.
93
  After 
being thoroughly washed, the particles were analyzed for carbohydrates using the 
phenol/sulfuric acid colorimetric assay.
 94
  This assay is able to detect carbohydrates in 
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concentrations as low as micrograms per milliliter.
94
   The conjugate that is produced in 
the reaction has a distinctive light-brown color and a strong absorbance at 490 nm.
94
 
Unfortunately, the particles tested negative for carbohydrates, indicating that lactose had 
not been coupled to the amine-functionalized surface.  Therefore, an alternative method 
using borate buffer (pH = 8.0) and high salt concentrations described by Gildersleeve et 
al. was attempted (Figure 15).
95
  The colorimetric assay of the resulting material was 
positive for carbohydrates, indicating that lactose was bound to the surface of the 
nanoparticles (Figure 16).  As a control, amine-functionalized fluorescent silica 
nanoparticles were treated with sucrose under identical reaction conditions.  Sucrose is a 
non-reducing sugar, and the glycosidic bonds of sucrose are not expected to hydrolyze 
under mildly basic reaction conditions.  Thus, under the reaction conditions described by 
Gildersleeve, sucrose should be incapable of undergoing reductive amination.  The 
amine-functionalized fluorescent silica nanoparticles that were treated with sucrose under 
the reductive amination reaction conditions tested negative for carbohydrates (Figure 16).  
This result indicates that lactose is bound to the surface of the nanoparticles through 
covalent linkages and not by hydrophobic or electrostatic interactions.   
 
































Figure 16 :  Absorbance spectra from the phenol/sulfuric acid colorimetric assay of 
lactose-functionalized fluorescent silica nanoparticles (blue) and sucrose treated, amine-
functionalized fluorescent silica nanoparticles (red).  Absorbance at 490 nm indicates the 
presence of carbohydrates within the sample. 
 
 
The absorance spectra shown are from the phenol/sulfuric acid colorimetric assay of one trial.  The results 
are representative
 
of the results from two individual trials.  In both cases, a stronger absorbance at 490 nm 




 Methods used to prepare protein- and carbohydrate-functionalized materials have 
been reviewed.  In general, protein- and carbohydrate-functionalized materials are 
prepared by one of two ways:  (1)  by synthetically introducing an anchor moiety into the 
protein or carbohydrate, which is used to covelantly attach the biomolecule to the suface 
of a specific material; or, (2)  by functionalizing the surface of a material with a 
functional group that will react to covalently attach a protein or carbohydrate to the 
material.  Bifunctional linker molecules are commonly used to prepare protein-
 25 
functionalized materials, while a variety of glycosylation methodologies are used to 
prepare carbohydrate-functionalized materials.  
 From the work presented here, there are several significant findings.  N-linked 
glycosyl siloxane derivatives, prepared via a modified Staudinger ligation method, were 
used to create carbohydrate-functionalized evanescent wave fiber Bragg gratings.  The 
carbohydrate-functionalized fibers were subsequently used to detect the specific binding 
of lectins to the carbohydrates attached to the surface of the fiber.   In addtion, it was 
found that N-linked pentenyl glycoside intermediates could undergo cross metathesis 
with terminal alkene derivatives containing a variety of anchor moieties.  The advantage 
of this synthetic strategy is the ability to create a series of carbohydrate derivatives 
capable of functionalizing a variety of different material from a common pentenyl 
glycoside intermediate.  Also, reductive amination proved to be a facile method to 







All compounds were used as received from the supplier unless otherwise stated.  
Methylene chloride (CH2Cl2), dimethyl formamide (DMF) and 1, 2-dichloroethane were 
distilled from calcium hydride.  Infrared spectra were obtained on a Nicolet 5DXC FT-IR 
sprctrophotometer.  Band positions are given in reciprocal centimeters (cm
-1
) and relative 





spectra were obtained on a Bruker DRX-400 MHz spectrometer.  Chemical shifts are 
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reported in parts per million (ppm) relative to CHCl3 (! 7.24).  Coupling constants (J 
values) are given in hertz (Hz).  Spin multiplicities are indicated by the following 
symbols:  s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet).  High resolution 
mass spectra (HRMS) were obtained on a JEOL Accu TOF-CS mass spectrometer using 
electrospray ionization (ESI).  An Ocean Optics USB 2000 Spectrometer was used to 
obtain absorbance spectra.  Room temperature (RT) is defined as 20
o
C.  All glassware 
was dried in an oven set to 120 
o
C for at least 12 hours before use.   
 











!-Glucose pentaacetate (2.4 g, 6.2 mmol) was dissolved in 25 mL of freshly distilled 
CH2Cl2 under an argon atmosphere. Trimethylsilyl azide (1.2 mL, 9.3 mmol) was added 
via syringe followed by a 1.0 M solution of SnCl4 (3.1 mL, 3.1 mmol) via syringe.  The 
reaction mixture stirred at RT for 21.5 hours.  The reaction mixture was then diluted with 
100 mL of CH2Cl2 and washed twice with saturated NaHCO3 solution and then four 
times with H2O.  The organic layer was collected, dried over MgSO4, and concentrated in 
vacuo to yield a colorless oil.  The oil was recrystallized from EtOAc and hexanes to 














Glucose azide 1  (1.0 g, 2.7 mmol) was dissolved in 25 mL of freshly distilled CH2Cl2.  
Diisopropylethylamine (1.0 mL) was added via syringe followed by a 1.0 M solution of 
trimethylphosphine (3.5 mL, 3.5 mmol) via syringe.  Evolution of gas was observed.  The 
reaction mixture stirred at RT for 30 minutes.  4-Pentenoic acid (0.6 mL, 5 mmol) was 
added via syringe in one aliquot.  The reaction mixture stirred at RT for 22 hours.  The 
reaction mixture was then diluted with 125 mL of EtOAc and washed three times with 
H2O.  The organic layer was collected, dried over MgSO4 and concentrated in vacuo to 
yield a colorless oil.  Purification of the oil by flash chromatography (hexanes: EtOAc, 
1:1) gave 0.62 g (54%) of alkene 2  as a colorless oil. Spectral data were identical to the 























Glucose alkene 2  (0.43 g, 1.0 mmol) and PtO2 (0.01 g, 0.05 mmol) were added into a vial 
and dissolved with 1.5 mL of freshly distilled THF.  Triethoxysilane (0.9 mL, 5 mmol) 
was added via syringe in one portion.  The vial was flushed with argon and sealed.  The 
reaction mixture stirred at 95
 o
C for 3 hours.  The reaction mixture was diluted with 20 
mL of EtOH and filtered through a Celite plug.  Concentration in vacuo yielded a 
colorless oil.  Purification by flash chromatography (hexanes : EtOAc, 1:1) gave 0.42 g 
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of an inseparable mixture of siloxane 3  and amide 4 .  The mol ratio of 3 : 4  (3:1)  and 
percent yields (57% for 3  and 18% for 4) were determined by integration of the 
1
H-NMR 
signals at 0.60 ppm (corresponding to the protons on the carbon adjacent to the siloxane 
group in 3) and 0.88 ppm (corresponding to the protons on the terminal carbon in 4). 

















To a refluxing mixture of NaOAc (2.7 g, 33 mmol) in acetic anhydride (24 mL) was 
added !-D-lactose (3.0 g, 8.3 mmol) in three equal portions over 30 minutes.  The 
mixture stirred at reflux (150 
o
C) for 3 hours.  After 3 hours, the reaction mixture had 
turned dark brown.  The mixture was cooled to 100
 o
C and added to 200 mL of an 
ice/water mixture.  This heterogeneous mixture was vigorously stirred at RT for 18 h.  
After 18 hours, a precipitate had formed.  The water was decanted and the precipitate was 
dissolved in 75 mL of CH2Cl2.  The organic layer was washed twice with saturated 
NaHCO3 and then three times with H2O.  The organic layer was collected, dried over 
MgSO4, and concentrated in vacuo to yield an orange/brown colored oil.  
Recrystallization from CH2Cl2 and diethyl ether yielded 3.2 g (60%) of peracetylated 

















Lactose azide  
Peracetylated lactose (1.6 g, 2.4 mmol) was dissolved in 15 mL of freshly distilled 
CH2Cl2.  Trimethylsilyl azide (1.2 mL, 9.3 mmol) was added via syringe followed by a 
1.0 M solution of SnCl4 (3.1 mL, 3.1 mmol) via syringe.  The mixture was stirred at RT 
for 40 hours under argon atmosphere.  The mixture was then diluted with 50 mL of 
CH2Cl2 and washed three times with saturated NaHCO3 and then three times with H2O.  
The organic layer was collected and dried over MgSO4 and concentrated in vacuo to yield 
a colorless oil. Purification by flash chromatography (hexanes : EtOAc, 3:7) gave 1.34 g 
(85%) of the lactose azide conjugate as a colorless oil.  Spectral data were identical to the 


















Lactose azide conjugate (0.6 g, 0.9 mmol) was dissolved in 25 mL of freshly distilled 
CH2Cl2.  Diisopropylethylamine (0.3 mL) was added via syringe followed by a 1.0 M 
solution of trimethylphosphine (1.4 mL, 1.4 mmol) via syringe.  Evolution of gas was 
observed.  After the reaction mixture stirred at RT for 0.5 h,  4-pentenoic acid (0.2 mL, 
1.8 mmol) was added via syringe.  The reaction mixture stirred at RT for 20 hours.  The 
reaction mixture was then diluted with 70 mL of EtOAc and washed three times with 
H2O.  Organic layer was collected and dried over MgSO4 and concentrated in vacuo to 
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yield a colorless oil.  Purification of the oil by flash chromatography (hexanes : EtOAc, 
1:9) gave 0.3 g (48%) of alkene 5  as a colorless oil. Spectral data were identical to the 
































6 7  
Alkene 5  (0.140 g, 0.19 mmol)  and PtO2 (0.003 g, 0.01 mmol) were weighed into a vial 
and dissolved with 0.3 mL of freshly distilled THF.  Triethoxysilane (0.2 mL, 1.0 mmol) 
was added via syringe.  The vial was flushed with argon and tightly capped.  Reaction 
mixture stirred at 95
 o
C for 3 hours.  The reaction mixture was diluted with 20 mL of 
EtOH and filtered through a Celite plug.  Concentration in vacuo yielded a colorless oil.  
Purification by flash chromatography (hexanes : EtOAc, 2:8) gave 0.128 g of an 
inseparable mixture of siloxane 6  and amide 7 . The mol ratio of 6 :7  (2:1) and percent 
yields (52% for 6  and 30% for 7)  were determined by integration of the 
1
H-NMR signals 
at 0.60 ppm (corresponding to the protons on the carbon adjacent to the siloxane group in 
6) and 0.88 ppm (corresponding to the protons on the terminal carbon in 7). Spectral data 












Peracetylated Mannose  
To a refluxing mixture of NaOAc (1.8 g, 23 mmol) in acetic anhydride (20 mL) was 
added mannose (1.0 g, 5.5 mmol) in three equal portions over 30 minutes.  The mixture 
stirred at reflux for 3 hours.  After 3 hours, the reaction mixture had turned a dark brown 
color.  The mixture was cooled to 100
 o
C and added to 200 mL of an ice/water mixture.  
This heterogeneous mixture vigorously stirred at RT for 18 hours.  The reaction mixture 
was transferred to a separatory funnel and 75 mL of CH2Cl2 was added.  The organic 
layer was washed with saturated NaHCO3 (2 x 50 mL) and H2O (2 x 50 mL).  The 
organic layer was collected, dried over MgSO4 and concentrated in vacuo to yield a crude 
oil.  Purification by flash chromatography (hexanes: EtOAc, 1:1) gave 2.1 g (99%) of   
peracetylated mannose (! : ", 2.3 : 1) as a colorless, viscous oil. Spectral data were 
identical to the data reported by Park.
 97 
 The ! : " ratio was determined by integration of 
the 
1
H-NMR signals at 5.84 ppm (corresponding to the anomeric proton of the "-anomer) 









Peracetylated mannose (1.6 g, 4.2 mmol) was dissolved in 20 mL of freshly distilled 
CH2Cl2.  Trimethylsilyl azide (0.8 mL, 6.3 mmol) was added via syringe followed by 1.0 
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M SnCl4 (2.1 mL, 2.1 mmol) via syringe.  The mixture was stirred at RT for 40 hours 
under argon atmosphere.  The mixture was diluted with 50 mL of CH2Cl2 and washed 
three times with saturated NaHCO3 and then three times with H2O.  The organic layer 
was collected and dried over MgSO4 and concentrated in vacuo to yield 1.4 g (88%) of 
crude azide 8  as a colorless oil.  This crude product was taken to the next synthetic step 







2-Pyr idyl thioester  of pentenoic acid  
2, 2’-Dipyridyl disulfide (2.6 g, 12 mmol) and triphenylphosphine (3.2 g, 12 mmol) were 
dissolved in freshly distilled THF (15 mL).  4-Pentenoic acid (0.8  mL, 8 mmol) was 
added to the reaction mixture via syringe in one aliquot.  Reaction mixture stirred under 
argon atmosphere at RT for 20 hours.  Reaction mixture was concentrated in vacuo.  
Purification by flash chromatography (hexanes:EtOAc, 2:1) gave 1.7 g (100%) of the 
thioester.  IR (CCl4) 3084 (m), 3068 (m), 3056 (m), 2986 (m), 2921 (m), 2851 (m), 1711 
(s), 1572 (s), 1421 (s); 1H NMR (CDCl3) ! 2.42-2.48 (m, 2H), 2.79 (t, J = 7.6, 2H), 5.01-
5.11 (m, 2H), 5.76-5.86 (m, 1H), 7.24-7.29 (m, 1H), 7.59 (d, J = 8.0, 1H), 7.72 (dt, J = 












A solution of azide 8  (0.7 g, 2 mmol) dissolved in freshly distilled 1, 2-dichloroethane 
(20 mL) was transferred to a flask under argon atmosphere containing 4 A molecular 
sieves and triphenyphosphine (0.58 g, 2.2 mmol) via syringe in one aliquot.  The reaction 
mixture was heated to reflux under argon atmosphere for 19 hours without stirring and 
then cooled to RT.  The 2-pyridyl thioester of pentenoic acid (0.48 g, 2.5 mmol) was 
added to the reaction mixture via syringe.  Cupric chloride (CuCl2) (0.35 g, 2.6 mmol) 
was added to the reaction mixture under argon flow.  Reaction mixture stirred at RT for 
60 hours.  The  reaction mixture was filtered and the molecular sieves were washed with 
CH2Cl2  (3 x 15 mL).  The organic layer was washed with H2O (4 x 25 mL) dried over 
MgSO4, and concentrated in vacuo.  Purification by flash chromatography 
(hexanes:EtOAc, 1:1) yielded 0.30 g (35%) of alkene 10 .  IR (CCl4) 3640 (w), 3452 (w), 
2978 (s), 2978 (m), 2925 (m), 1760 (s), 1715 (m), 1229 (s); 1H NMR (CDCl3) ! 1.94-
2.10 (m, 9H), 2.20 (s, 3H), 2.22-2.38 (m, 4H), 3.75 (dq, J = 2.0, 5.2, 1H), 4.06 (dd, J = 
2.0, 12.4, 1H), 4.30 (dd, J = 4.8, 12.4, 1H), 4.99-5.33 (m, 5H), 5.54 (dd, J = 0.8, 9.6, 1H), 
5.72-5.81 (m, 1H), 6.09 (d, J = 9.6, 1H); 
13
C NMR (100 MHz, CDCl3)  ! 20.6, 20.8, 20.9, 























Alkene 10  (0.14 g, 0.33 mmol)  and PtO2 (0.004 g, 0.015 mmol) were weighed into a vial 
and dissolved in 0.3 mL of freshly distilled THF.  Triethoxysilane (0.3 mL, 1.6 mmol) 
was added to the reaction mixture via syringe in one portion.  The vial was flushed with 
argon and sealed.  The reaction mixture stirred at 95
 o
C for 3 hours, was diluted with 20 
mL of EtOH, and filtered through a celite plug.  Concentration in vacuo yielded a 
colorless oil.  Purification by flash chromatography (hexanes : EtOAc, 1 : 1) gave 0.12 g 
of an inseparable mixture of siloxane 11  and amide 12 . The mol ratio of 11 :12  (2.8:1) 
and percent yields (48% for 11  and 18% for 12)  were determined by integration of the 
1
H-NMR signals at 0.61 ppm (corresponding to the protons on the carbon adjacent to the 
siloxane group in 11) and 0.88 ppm (corresponding to the protons on the terminal carbon 
in 12):  IR (CCl4) 3448 (w), 2974 (w), 2925 (w), 2880 (w), 1760 (s), 1711 (s), 1221 (s); 
1H NMR (CDCl3) ! 0.61 (t, J = 8.4, 2H), 0.885 (t, J = 7.6, 1H), 1.18-1.42 (m, 12H), 1.45-
1.67 (m), 1.96-2.23 (m, 18H), 3.73-3.86 (m, 6H) , 4.03-4.12 (m, 1H), 4.27-4.33 (m, 1H), 
5.06-5.10 (m, 1H), 5.21 (t, J = 10.0, 1H), 5.33-5.34 (m, 1H), 5.53-5.56 (m, 1H), 6.05 (d, J 
= 9.2, 1H).  
13
C NMR (100 MHz, CDCl3)  ! 10.4, 13.3, 18.5, 20.7, 20.9, 20.9, 21.0, 21.1, 
22.4, 22.7, 27.3, 28.5, 36.3, 36.4, 58.6, 62.4, 65.3, 70.4, 70.4, 71.8, 74.3, 76.1, 77.4, 
169.6, 170.0, 170.5, 170.9, 172.5, 172.6; HRMS (ESI+) cacld. for C25H44NO13Si [M + 
H]
+  
594.2582, found 594.2613; HRMS (ESI+) cacld. for C19H30NO10 [M + H]
+  















Methyl acrylate (0.1 mL, 1 mmol) was added via syringe to a solution of 2  (0.051 g, 0.12 
mmol) dissolved in freshly distilled 1, 2 dichloroethane.  Grubb’s second-generation 
metathesis catalyst A  (0.01 g, 10 mol %) was added to the reaction mixture under argon 
flow.  The reaction mixture stirred at 65 
o
C for 22 hours.  The reaction mixture was 
concentrated in vacuo and purified by flash chromatography (hexanes : EtOAc, 1:1) to 
give 0.04 g (67%) of ester 13  as a mixture of E/Z isomers.  The mixture was a light 
purple powder:  IR (CCl4)  3432 (w), 2962 (m), 2925 (m), 2872 (w), 2851 (w), 1744 (s), 
1658 (w), 1511 (m), 1433 (m), 1368 (m), 1221 (s), 1045 (s); 
1
H NMR (CDCl3) ! 1.99-
2.05 (m, 12H), 2.27-2.51 (m, 4H), 3.68 (s, 3H), 3.79 (dq, J = 2.0, 10.0, 1H), 4.05 (dd, J = 
2.0, 12.4, 1H), 4.28 (dd, J = 4.0, 12.4, 1H), 4.87 (t, J = 9.6, 1H), 5.03 (t, J = 9.6, 1H), 5.22 
(t, J = 9.6, 1H), 5.28 (t, J = 9.6, 1H), 5.81 (td, J = 2.0, 16.0, 1H), 6.28 (d, J = 9.2, 1H), 
6.88 (dt, J = 6.8, 15.6, 1H); 
13
C NMR (100 MHz, CDCl3)  ! 21.0, 21.0 (2 C), 21.1, 27.4, 
34.7, 51.9, 62.0, 68.5, 71.0, 73.0, 73.3, 74.0, 78.6, 122.4, 147.0, 167.1, 170.0, 170.3, 
171.0, 171.6, 172.0; HRMS (ESI+) cacld. for C21H30NO12 [M + H]
+  
488.1768, found 
















Vinyl triethoxysilane (0.1 mL, 0.5 mmol) was added via syringe to a solution of  2  (0.051 
g, 0.12 mmol) dissolved in freshly distilled CH2Cl2..  Grubb’s second-generation catalyst 
A  (0.01 g, 10 mol %) was added under argon, and the reaction mixture stirred at 40 
o
C 
for 20 hours.  The reaction mixture was concentrated in vacuo and purified by flash 
chromatography (hexanes : EtOAc, 6:4) to give 0.045 g (63%) of siloxane 14 as a 
mixture of E/Z isomers (E:Z, 5.5:1).  The mixture was a dark, viscous oil:  IR (CCl4)  
3434 (w), 2973 (m), 2932 (m), 2879 (m), 1765(s), 1706 (m), 1549 (s), 1222 (s);  
1
H NMR 
(400 MHz, CDCl3) ! 1.19-1.26 (m, 9H), 1.97-2.06 (m, 12H), 2.22-2.57 (m, 4H), 3.76-
3.875 (m, 7H), 4.05 (dd, J = 1.6, 12.4, 1H), 4.29 (dd, J = 4.0, 12.4, 1H), 4.88 (t, J = 9.6, 
1H), 5.04 (t, J = 9.6, 1H), 5.19-5.30 (m, 2H), 5.34-5.45 [2d, 5.36, J = 14.4 (Z-isomer), 
5.43, J = 18.8 (E-isomer), 1H], 6.18 (d, J = 9.4, 1H), 6.27 (d, J = 9.4, 0.2H), 6.32-6.42 (m, 
1H); 
13
C NMR (100 MHz, CDCl3) ! 18.6, 21.0 (2 C), 21.1, 21.1, 31.7, 35.3, 58.9, 62.0, 
68.5, 71.0, 73.0, 73.9, 78.6, 121.0, 151.0, 170.0, 170.3, 171.0, 171.6, 172.7; HRMS 
(ESI+) cacld. for C25H42NO13Si [M + H]
+  
592.2425, found 592.2390.  The E/Z ratio was 
determined by integration of the 
1
H-NMR signals at 6.18 ppm (corresponding to the 
proton of the amide in the E isomer) and 6.27 ppm (corresponding to the proton of the 





1-Octenyl thioacetate  
8-Bromo-1-octene (0.57 g, 3.0 mmol) was added via syringe to a solution of potassium 
thioacetate (1.05 g, 9.0 mmol) dissolved in freshly distilled DMF (8.0 mL).  The reaction 
mixture stirred at RT for 30 hours.  The reaction mixture was then diluted in 50 mL of a 
1:1 mixture of hexanes and EtOAc and washed with H2O (2 x 25 mL).  The organic layer 
was dried over MgSO4 and concentrated in vacuo.  Purification by flash chromatography 
(hexanes : EtOAc, 98:2) yielded 1-octenyl thioacetate (0.60 g, 100%) as a yellow liquid:  
IR (CCl4) 3366 (w), 3076 (w), 2978 (m), 2929 (s), 2855 (s), 1691 (s), 1642 (m), 1352 
(m), 1135 (s); 
1
H NMR (400 MHz, CDCl3) ! 1.24-1.32 (m, 6H), 1.51-1.58 (m, 2H), 1.99-















1-Octenyl thioacetate (0.070g, 0.4 mmol) was added via syringe to a solution of  2  (0.150 
g, 0.4 mmol) dissolved in freshly distilled CH2Cl2.  Grubb’s second-generation catalyst A  
(0.03 g, 10 mol %) was added under argon, and the reaction mixture stirred at 40 
o
C for 
20 hours.  The reaction mixture was concentrated in vacuo and purified by flash 
chromatography (hexanes : EtOAc, 7:3) to give 0.070 g (35%) of thioester 15  as a 
mixture of E/Z isomers (E:Z, 3:1).  The mixture was a tan, viscous oil:  IR (CCl4) 3432 
(w), 2933 (m), 2851 (m), 1760 (s), 1695 (s), 1511 (m), 1368 (m), 1221 (s); 
1
H NMR (400 
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MHz, CDCl3) ! 1.23-1.34 (m, 5H), 1.54-1.62 (m, 4H), 1.91-2.06 (m, 14H), 2.15-2.25 (m, 
6H), 2.83 (t, J = 7.2, 2H), 3.80 (dt, J = 2.0, 10.0, 1H), 4.05 (dd, J = 2.0, 12.4, 1H), 4.29 
(dd, J = 4.0, 12.4, 1H), 4.88 (t, J = 9.6, 1H), 5.04 (t, J = 9.6, 1H), 5.16-5.46 (m, 4H), 6.20 
(d, J = 9.6, 1H), 6.36 (d, J = 9.6, 0.3H); 
13
C NMR (100 MHz, CDCl3) ! 21.0, 21.0 (2 C), 
21.1, 28.3, 28.7, 28.8, 29.4, 29.5, 29.7, 29.8, 31.0, 32.8, 36.9, 62.1, 68.5, 71.0, 73.1, 73.9, 
78.5, 128.2, 132.3, 170.0, 170.3, 171.1, 171.4, 173.3, 196.6; HRMS (ESI+) cacld. for 
C24H36NO11S [M + H]
+  
546.2009, found 546.1997.  The E/Z ratio was determined by 
integration of the 
1
H-NMR signals at 6.20 ppm (corresponding to the proton of the amide 













Allyl Benzyl ether (0.10, 0.70 mmol) was added via syringe to a solution of  2  (0.06 g, 
0.14 mmol) dissolved in freshly distilled CH2Cl2..  Grubb’s second-generation catalyst A  
(0.01 g, 10 mol %) was added under argon, and the reaction mixture stirred at 40 
o
C for 
24 hours.  The reaction mixture was concentrated in vacuo and purified by flash 
chromatography (hexanes : EtOAc, 3:7) to give 0.02 g (25%) of ether 16  as a mixture of 
E/Z isomers (E:Z, could not be determined by 
1
H NMR).  The mixture was a tan, viscous 
oil:  IR (CCl4) 3432 (w), 3027 (w), 2953 (w), 2925 (w), 2885 (w), 1760 (s), 1707 (s), 
1548 (m), 1511 (m), 1229 (s), 1045 (s);  
1
H NMR (400 MHz, CDCl3) ! 2.00-2.06 (m, 
12H), 2.22-2.36 (m, 4H), 3.80 (dq, J = 2.0, 10.0, 1H), 3.93 (d, J = 5.2, 1H) 4.05 (dd, J = 
2.0, 12.4, 1H), 4.29 (dd, J = 4, 12.4, 1H), 4.47 (s, 1H), 4.88 (t, J = 9.6, 1H), 5.04 (t, J = 
 39 
9.6, 1H), 5.20-5.30 (m, 3H), 5.61-5.67 (m, 1H), 6.19 (d, J = 9.2, 1H), 7.24-7.32 (m, 5H).
 
13
C NMR (100 MHz, CDCl3) ! 21.0 (2 C), 21.1, 21.2, 27.9, 36.2, 62.0, 68.5, 70.9, 71.0, 
72.6, 73.1, 74.0, 78.6, 128.0, 128.2, 128.8, 129.0, 132.2, 138.6, 170.0, 170.3, 171.1, 
172.0, 172.9; HRMS (ESI+) cacld. for C27H36NO11 [M + H]
+  
















Vinyl triethoxysilane (0.3 mL, 1.5 mmol) was added via syringe to a solution of alkene 5  
(0.13 g, 0.20 mmol) dissolved in freshly distilled CH2Cl2.  Grubb’s second-generation 
catalyst A  (0.02 g, 10 mol %) was added under argon, and the reaction mixture stirred at 
40 
o
C for 20 hours.  Reaction mixture was concentrated in vacuo and purified by flash 
chromatography (hexanes:EtOAc, 8:2) to give 0.08 g (50%) of siloxane 18  as a mixture 
of E/Z isomers (E:Z, 3:1).  The mixture was a dark, viscous oil:  IR (CCl4) 3427 (w), 
2974 (w), 2925 (w), 2884 (w), 1756 (s), 1707 (s), 1552 (m), 1213 (s), 1074 (s); 
1
H NMR 
(400 MHz, CDCl3) ! 1.17-1.24 (m, 9H), 1.93-2.415 (m, 25H), 3.70-3.85 (m, 8H), 4.01-
4.14 (m, 3H), 4.37-4.45 (2H), 4.76-4.82 (m, 1H), 4.90 (dd, J = 3.6, 10.4, 1H), 5.05-5.43 
(m, 5H), 6.10 (d, J = 9.2, 1H), 6.18 (d, J = 9.2, 0.29H), 6.35 (dt, J = 6.0, 18.8, 1H); 
13
C 
NMR (100 MHz, CDCl3) ! 18.6, 18.6, 20.9, 21.0, 21.1 (2 C), 21.1 (2 C), 21.2, 21.3, 31.7, 
35.3, 58.9, 61.3, 62.4, 67.0, 69.4, 71.1, 71.4, 72.7, 74.8, 76.4, 78.5, 101.3, 120.9, 151.1, 
169.4, 169.7, 169.8, 170.5, 170.6, 170.7, 170.8, 171.8, 172.5; HRMS (ESI+) cacld. for 
C37H58NO21Si [M + H]
+  
880.3271, found 880.3264.  The E/Z ratio was determined by 
 40 
integration of the 
1
H-NMR signals at 6.10 ppm (corresponding to the proton of the amide 
in the E isomer) and 6.18 ppm (corresponding to the proton of the amide in the Z isomer).  
 
4.3 Preparation of Glucose-Functionalized Glass  
 A glass cover slip (Fisherbrand Microscope Cover Glass) was immersed in piranha 
solution (3 : 1 concentrated H2SO4 : 30% H2O2 ) for 1 hour, rinsed with Millipore H2O 
(50 mL), and then immersed in 7 : 1 bu!ered oxide etch with surfactant from J. T. Baker 
for 1 hour. The slide was then rinsed with Millipore H2O followed by sonication in 
Millipore H2O for 10 minutes. The sonication process was repeated with fresh Millipore 
water. The slide was then rinsed with dichloromethane (50 mL) and dried in an oven at 
200 
!
C for 1.5 hours. After cooling in a desiccator, a solution of glucose-siloxane 1 
dissolved in dichloromethane was added drop wise to one side of the glass slide. After 
sitting undisturbed under nitrogen atmosphere for 30 minutes, the glucose 
siloxane/dichloromethane solution was reapplied. The glass slide sat undisturbed under 
nitrogen atmosphere for an additional 30 minutes. The glass slide was rinsed with 
dichloromethane (20 mL) and was allowed to sit undisturbed under nitrogen atmosphere 
for 12 hours.  
 
4.4 XPS Analysis of Bare and Glucose-Functionalized Glass Slides 
 The XPS data was collected on a Kratos Axis 165 X-ray photoelectron 
spectrometer operating in hybrid mode using monochromatic Al K" radiation. The 
instrument maintained a pressure of 5 # 10
$ 9
 Torr or better during data collection. The 
data were collected at a 20
!
 take-off-angle (with respect to the sample plane). Charge 
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neutralization was required to compensate for sample charging. Survey spectra (not 
shown here) were collected at a pass energy of 160 eV, while high resolution spectra 
were collected at a pass energy of 20 eV. All spectra were calibrated to the hydrocarbon 
peak at 285 eV. The C 1s spectra were !t with a Shirley background and peaks of a  
30% Lorentzian 70% Gaussian product function.  
 
4.5 Preparation of Glucose-Functionalized Bragg Fiber 
 A fiber Bragg grating sensor, etched to a diameter of 5 µm, was immersed in a 
solution of glucose-siloxane conjugate 3  in 95% ethanol for 1 hour at 25 
o
C.  The fiber 
was then immersed in a 0.2M NaOEt/EtOH solution for 2 hours at 25 
o
C.  The fiber was 
removed from the sodium ethoxide solution and rinsed with ethanol and then Millipore 
water. 
 
4.6 Preparation of APTES-Functionalized Fluorescent Silica Nanoparticles 
Fluorescent silica nanoparticles were prepared as described in chapter 3 of this 
dissertation.  To an evenly dispersed suspension of fluorescent silica nanoparticles (0.01 
g) in toluene (5 mL) was added 3-aminopropyltriethoxysilane (APTES) (1mL; 0.95 g; 4.3 
mmol).  The reaction mixture stirred at room temperature for 2 hours under an argon 





4.7 Preparation of Lactose-Functionalized Fluorescent Silica Nanoparticles via 
Reductive Amination 
APTES-functionalized fluorescent silica nanoparticles were evenly suspended in 
borate buffer (2.5 mL, pH = 8.0).  A solution of NaCl (0.15 g) in borate buffer (0.5 mL) 
was added to make a 1M NaCl solution.  Lactose (0.05 g; 0.15 mmol) in borate buffer 
(0.5 mL) was added to the reaction mixture followed by NaCNBH3 (0.05 g; 0.80 mmol) 
in borate buffer (0.5 mL).  The reaction mixture stirred at room temperature for 4 days.  
The particles were then washed with Millipore water (4 x 5 mL) and resuspended in 
Millipore water (1mL).   
 
4.8 Phenol/Sulfuric Acid Colorimetric Assay  
A 0.25 mL aliquot of lactose-functionalized fluorescent silica nanoparticles  
(0.005 g) suspended in Millipore water (1 mL) was placed in a glass test tube.  0.125 mL 
of a 0.53 M phenol/H2O solution was added to the suspension, followed by 0.625 mL of 
concentrated H2SO4 (the stream of acid was directed toward the surface of the solution 
rather than against the side of the test tube).  After 10 minutes, the samples were gently 
vortexed.  After the solution sat undisturbed for an additional 30 minutes, the absorbance 
of the solution was measured using an Ocean Optics USB 2000 Spectrometer.   
 
Acknowledgements 
 The author acknowledges Christopher Stanford, Geunmin Ryu, Mario Dagenais, 
and Karen Gaskell for the significant contributions they made to the research and 




1) de la Fuente, J. M.; Penades, S.  Biochim. Biophys. Acta. Gen. Subj.  2006 , 
1760, 636-651. 
2) Ojeda, R.; de Paz, J. L.; Barrientos, A. G.; Martin-Lomas, Manuel; Penades, S. 
Carbohydr. Res.  2007 , 342, 448-459.  
3) Katz, E.,; Willner, I.  Angew. Chem., Int. Ed.  2004 , 43, 6042-6108. 
 
4) Niemeyer, C. M.  Angew. Chem., Int. Ed.  2001 , 40, 4128-4158. 
 
5) Blodgett, K. B.  J. Am. Chem. Soc.  1935 , 57,1007-1022. 
 
6) Blodgett, K. B.; Langmuir, I.  Phys. Rev.  1937 , 51, 964-982. 
 
7) Bigelow, W. C.; Pickett, D. L.; Zisman, W. A.  J. Colloid Sci.  1946 , 1, 513. 
 
8) Bain, C. D., Troughton, E. B.  J. Am. Chem. Soc.  1989, 111, 321-35. 
 
9) Ulman, A.  Chem. Rev.  1996 , 96, 1533-1554. 
 
10) Love, J. C., Estroff, L. A.; Kriebel, J. K.; Nuzzo, R. G.; Whitesides, G. M.  Chem. 
Rev.  2005 , 105, 1103-1169. 
11) Nuzzo, R. G., Allara, D. L.  J. Am. Chem. Soc.  1983 , 105, 4481-4483. 
 
12) Nuzzo, R. G.; Zegarski, B. R.; Dubois, L. H.  J. Am. Chem. Soc.  1987 , 109, 
733-740. 
13) Troughton, E. B; Bain, C. D.; Whitesides, G. M.; Nuzzo, R. G.; Allara, D. L.; 
Porter, M.  Langmuir  1988 , 4, 365-385. 
14) Lee, L.-H. SPI (Soc. Plast. Ind.) Reinf. Plast./Compos. Div., Annu. Tech. Conf., 
Proc., 23rd 1968 , 9D-1-9D-14. 
15) Lee, L.-H.  J. Colloid Interf. Sci.  1968 , 27, 751-60. 
 
16) Zisman, W. A.  Ind. Eng. Chem., Prod. Res. Develop.  1969 , 8, 98-111. 
 
 44 
17) Sagiv, J.  J. Am. Chem. Soc.  1980 , 102, 92-98. 
 
18) Kahn, F. J.; Taylor, G. N.; Schonhorn, H. Proc. IEEE.  1973 , 61, 823-8. 
 
19) Silverman, B. M.; Wieghaus, K. A.; Schwartz, J.  Langmuir  2005 , 21, 225-228. 
 
20) Cattani-Scholz, A.; Pedone, D.; Dubey, M.; Neppl, S.; Nickel, B.; Feulner, P.; 
Schwartz, J.; Abstreiter, G.; Tornow, M.  ACS Nano  2008 , 2, 1653-1660. 
21) Tsoi, S.; Fok, E.; Sit, J. C.; Veinot, J. G. C.  Chem. Mater.  2006 , 18, 5260-5266. 
 
22) Wu, W.; He, Q.; Jiang, C.  Nanoscale Res. Lett.  2008 , 3, 397-415. 
 
23) Allara, D. L.; Nuzzo, R. G.  Langmuir  1985 , 1, 45-52. 
 
24) Ogawa, H.; Chihera, T.; Taya, K.  J. Am. Chem. Soc.  1985 , 107, 1365-1369. 
 
25) Schlotter, N. E.; Porter, M.D.  Chem. Phys. Lett.  1986 , 132, 93. 
 
26) Tao, Y. T.  J. Am. Chem. Soc.  1993 , 115, 4350-4358. 
 
27) Howarter, J. A.; Youngblood, J. P.  Langmuir  2006 , 22, 11142-11147. 
 
28) Chinwangso, P.; Jamison, A. C.; Lee, T. R. Acc. Chem. Res.  2011 , 44, 511-519. 
 
29) Wu, W.; He, Q.; Jiang, C. Nanoscale Res. Lett.  2008 , 3, 397-415. 
 
30) Caruso, F.  Adv. Mater.  2001 , 13, 11-22. 
 
31) Willner, I.; Katz, E. Angew. Chem., Int. Ed.  2000 , 39, 1181-1218. 
 
32) Nobs, L.; Buchegger, F.; Gurny, R.; Allemann, E. J. Pharm. Sci.  2004 , 93, 1980-
1992. 
33) Houseman, B. T.; Gawalt, E. S.; Mrksich, M. Langmuir  2003 , 19, 1522-1531. 
 
34) Zhang, Q.; Huang, R. F.; Guo, L.-H. Chin. Sci. Bull.  2009 , 54, 2620-2626. 
 
35) Wu, Y.; Chen, C.; Liu, S. Anal. Chem.  2009 , 81, 1600-1607. 
 
36) Tang, D.; Su, B.; Tang, J.; Ren, J.; Chen, G. Anal. Chem.  2010 , 82, 1527-1534. 
 
37) Lahiri, J.; Isaacs, L.; Tien, J.; Whitesides, G. M. Anal. Chem.  1999 , 71, 777-90. 
 
 45 
38) Azioune, A.; Ben Slimane, A.; Hamou, L. A.; Pleuvy, A.; Chehimi, M. M.; 
Perruchot, C.; Armes, S. P. Langmuir  2004 , 20, 3350-3356. 
39) Kim, M. I.; Ham, H. O.; Oh, S.-D.; Park, H. G.; Chang, H. N.; Choi, S.-H. J. Mol. 
Catal. B: Enzym. 2006 , 39, 62-68. 
40) Wang, Z.; Miu, T.; Xu, H.; Duan, N.; Ding, X.; Li, S. J. Microbiol. Methods.  
2010 , 83, 179-184. 
41) Zhang, X.; Song, C.; Chen, L.; Zhang, K.; Fu, A.; Jin, B.; Zhang, Z.; Yang, K. 
Biosens. Bioelectron.  2011 , 26, 3958-3961. 
42) Wei, H.; Zhou, L.; Li, J.; Liu, J.; Wang, E. J. Colloid Interf. Sci.  2008 , 321, 310-
314. 
43) Betancor, L.; Lopez-Gallego, F.; Hidalgo, A.; Alonso-Morales, N.; Cesar Mateo, 
G. D.-O.; Fernandez-Lafuente, R.; Guisan, J. M. Enzyme Microb. Technol.  
2006 , 39, 877-882. 
44) Xu, H.; Zhang, Z. Biosens. Bioelectron.  2007 , 22, 2743-2748. 
45) Angeloni, S.; Ridet, J. L.; Kusy, N.; Gao, H.; Crevoisier, F.; Guinchard, S.; 
Kochhar, S.; Sigrist, H.; Sprenger, N. Glycobiology  2004 , 15, 31-41. 
46) Sigrist, H.; Collioud, A.; Clemence, J.-F.; Gao, H.; Luginbuehl, R.; Saenger, M.; 
Sundarababu, G. Opt. Eng.  1995 , 34, 2339-48. 
47) Maltzahn, G.; Ren, Y.; Park, D.; Kotamraju, V. R.; Jayakumar, J.; Fogal, M.; 
Ruoslahti, E.; Bhatia, S.  Bioconjugate Chem.  2008 , 19, 1570-1578. 
48) Houseman, B. T.; Huh, J. H.; Kron, S. J.; Mrksich, M. Nat. Biotechnol. 2002 , 20, 
270-274. 
49) Godula, K.; Bertozzi, C. R. J. Am. Chem. Soc.  2010 , 132, 9963-9965. 
 46 
50) Zhi, Z.-L.; Powell, A. K.; Turnbull, J. E. Anal. Chem. 2006 , 78, 4786-4793. 
51) de Boer, A. R.; Hokke, C. H.; Deelder, A. M.; Wuhrer, M. Anal. Chem.  2007 , 
79, 8107-8113. 
52) Park, S.; Lee, M.-R.; Shin, I. Bioconjugate Chem. 2009 , 20, 155-162. 
53) Zhou, X.; Turchi, C.; Wang, D. J. Proteome Res. 2009 , 8, 5031-5040. 
54) Clo, E.; Blixt, O.; Jensen, K. J. Eur. J. Org. Chem.  2010 , 540-554. 
55) Toshima, K.; Tatsuta, K.  Chem. Rev.  1993 , 93, 1503-1531.  
56) Yoshimura, Y.; Shimizu, H.; Hinou, H.; Nishimura, S.  Tetrahedron Lett.  2005 , 
46, 4701-4705. 
57) Barrientos, A.; de la Fuente, J.; Rojas, T.; Fernandez, A.; Penades, S.  Chem. Eur. 
J.  2003 , 9, 1909-1921.  
58) Shimizu, H.; Sakamoto, M.; Nagahori, N.; Nishimura, S.  Tetrahedron  2007 , 63, 
2418-2425. 
59) Lin, C.; Yeh, Y.; Yang, C’; Chen, C.; Chen, G.; Chen, C.; Wu, Y.  J. Am. Chem. 
Soc.  2002 , 124, 3508-3509. 
60) Halkes, M. K.; de Souza, A. C.; Maljaars, E.; Gerwig, G.; Kamerling, J.  Eur. J. 
Org.Chem.  2005 , 3650-3659.   
61) Zhang, Y.; Luo, S.; Tang, Y.; Hou, K.; Cheng, J.; Zeng, X.; Wang, P. G.  Anal. 
Chem.  2006 , 78, 2001-2008. 
62) Boubbou, K.; Gruden, C.; Huang, X.  J. Am. Chem. Soc.  2007 , 129, 13392-
13393. 
63) Earhart, C.; Jana, N.; Erathodiyil, N.; Ying, J.  Langmuir  2008 , 24, 6215-6219.  
64) Damkaci, F.; DeShong, P.  J. Am. Chem. Soc.  2003 , 125, 4408-4409. 
 47 
65) Kadalbajoo, M.; Park, J.; Opdahl, A.; Suda, H.; Kitchens, C.; Garno, J.; Batteas, 
J.; Tarlov, M.; DeShong, P.;  Langmuir  2007 , 23, 700-707.  
66) De, M.; Ghosh, P. S.; Rotello, V. M. Adv. Mater.  2008 , 20, 4225-4241. 
67) Stanford, C. J.; Ryu, G.; Dagenais, M.; Hurley, M. T.; Gaskell, K. J.; De Shong, 
P.  J. Sens.  2009 , Article ID 982658. 
68) Ryu, G.; Dagenais, M.; Hurley, M. T.; De Shong, P.  IEEE J. Sel. Top. Quantum 
Electron.  2010 , 16, 647-653. 
69) Buskas, T.; Soderberg, E.; Konradsson, P.; Fraser-Reid, B.  J. Org. Chem.  2000 , 
65, 958-963. 
70) Chatterjee, A. K.; Morgan, J. P.; Scholl, M.; Grubbs, R. H.  J. Am. Chem. Soc.  
2000, 122, 3783-3784. 
71) Grubbs, R. H.  Tetrahedron  2004, 60, 7117-7140. 
72) Chatterjee, A.; Grubbs, R. H.  Angew. Chem., Int. Ed.  2002, 41, 3171-3174. 
73) O'Leary, D. J.; Blackwell, H. E.; Washenfelder, R. A.; Grubbs, R. H.  
Tetrahedron Lett.  1998, 39, 7427-7430. 
74) Chatterjee, A. K.; Grubbs, R. H.  Org. Lett.  1999, 1, 1751-1753. 
75) Blackwell, H. E.; O'Leary, D. J.; Chatterjee, A. K.; Washenfelder, R. A.; 
Bussmann, D. A.; Grubbs, R. H.  J. Am. Chem. Soc.  2000, 122, 58-71. 
76) Choi, T.-L.; Chatterjee, A. K.; Grubbs, R. H.  Angew. Chem., Int. Ed.  2001, 40, 
1277-1279. 
77) Chatterjee, A. K.; Sanders, D. P.; Grubbs, R. H.  Org. Lett.  2002, 4, 1939-1942. 
78) Chatterjee, A. K.; Choi, T.-L.; Sanders, D. P.; Grubbs, R. H.   J. Am. Chem. Soc.  
2003, 125, 11360-11370. 
 48 
79) O’Leary, D. J.; Blackwell, H. E.; Washenfelder, R. A.; Grubbs, R. H.  
Tetrahedron Lett.  1998, 39, 7427. 
80) Roy, R.; Das, S. K.  Chem. Commun.  2000, 519-529. 
81) Leeuwenburgh Michiel, A.; van der Marel Gijsbert, A.; Overkleeft Herman, S.  
Curr. Opin. Chem. Biol.  2003, 7, 757-765. 
82) Jorgensen, M.; Hadwiger, P.; Madsen, R.; Stutz, A. E.; Wrodnigg, T. M.  Curr. 
Org. Chem.  2000, 4, 565-588. 
83) Hu, Y.-J.; Roy, R.  Tetrahedron Lett.  1999, 40, 3305-3308. 
84) Vernall Andrea, J.; Abell Andrew, D.  Org. Biomol. Chem.  2004, 2, 2555-2557. 
85) Hadwiger, P.; Stutz, A. E.  Synlett.  1999, 1787-1789. 
86) Plettenburb, O.; Mui, C.; Bodmer-Narkevitch, V.; Wong, C.  Adv. Synth. Catal.  
2002, 344, 622-626. 
87) Bruchner, P.; Koch, D.; Voigtmann, Ulrike, Blechert, S.  Synth. Commun.  2007, 
37, 2757-2769. 
88) Timmer, M.; Chumillas, M. V.; Donker-Koopman, W.; Aerts, J. M. F. G.; van der 
Marel, G.; Overkleeft, H.  J. Carbohydr. Chem.  2005 , 24, 335-351. 
89)  Wan, Q.; Cho, Y. S.; Lambert, T.; Danishefsky, S.  J. Carbohydr. Chem.  2005 , 
24, 425-440. 
90) Otsuka, H.; Akiyama, Y.; Nagasaki, Y. Kataoka, K.  J. Am. Chem. Soc.  2001, 
123, 8226-8230. 
91) Houseman, B. T.; Mrksich, M.  Chem. Biol.  2002 , 9, 443-454. 
92) Vollhardt, D.  J. Phys. Chem. C.  2007 , 111, 6805-6812. 
93) Borch, R. F.; Bernstein, M. D.; Durst, H. D. J. Amer. Chem. Soc. 1971 , 93, 
 49 
2897-904. 
94) Dubois, M.; Gilles, K. A.; Hamilton, J. K.; Rebers, P. A.; Smith, F.  Anal. Chem.  
1956 , 28, 350-356. 
95) Gildersleeve, J. C.; Oyelaran, O.; Simpson, J. T.; Allred, B. Bioconjugate Chem. 
2008 , 19, 1485-1490. 
96) Damkaci, F.  Ph.D. Thesis, University of Maryland, College Park.  2004 . 




Chapter 2:  Mesoporous Silica as Controlled Release Devices:  Synthesis, 
Characterization, and pH-Sensitive Release 
 
1 Introduction 
Since the Mobil Corporation first introduced Mobil Crystalline Material (MCM)-
41
1
, a large body of research has been devoted to developing novel mesoporous silica 
materials with controlled pore size and uniform pore structure, such as Santa Barbara 
amorphous silica (SBA)-n,
2
 Michigan State University silica (MSU)-n,
 3 
folded sheet-
derived mesoporous silica (FSM)-16,
 4
 and Korean Institute of Technology silica (KIT)-
1.
5-7
  These porous silica materials are generally ten to hundreds of microns in dimension, 
contain regular, periodic pores in the mesoscale range (2-50 nm), and are used as 
catalysts and absorption/purification materials.
1, 7
  However, integrating mesopore 
formation strategies into standard silica nanoparticle synthesis lead to a new class of 
mesoporous materials that are now known as mesoporous silica nanoparticles (MSN).  
Researchers are able to create monodisperse MSN with high surface areas, large cavity 
volumes, and are able to easily functionalized the silica surface with a range of organic 
and biologically relevant molecules—making these porous materials ideal for controlled 
release systems and vehicles for the delivery of chemotherapeutics.
6-52  
This chapter 
reviews the methods that are used to synthesize mesoporous silica materials, and then 
focuses on the work that has been done by DeShong and coworkers to create MSN-based 




1.1 Preparation of Mesoporous Silica 
Mesoporous silica materials are synthesized by the templated polymerization of a 
silica precursor around amphiphilic surfactant or nonionic block copolymer self-
assembled mesophase structures.
1-3
  The surfactant scaffold is then removed via 
calcination or chemical extraction (Figure 17).  Electrostatic, hydrogen bonding, and van 
der Waals interactions between the surfactant and a silica species drive templation.
 53-54
  
For example, under alkaline conditions, formation of MCM-41 and MCM-48 occurs 







 is the cationic surfactant and I
-
 is the silicate anion.
 53-54
  Other MSN 
types, including SBA-1 and SBA-3, are formed in acidic media where the acid counter-
anion is used to mediate the coordination between cationic surfactants and positively 















 is a positively charged silica species.
53-54
 
In aqueous solutions, above critical micelle concentrations, surfactants form 
micelles, vesicles, and/or microemulsions.  However, at higher concentrations (30% by 
wt. or greater), surfactant micelles and polar lipids self-assemble into a range of lyotropic 
liquid-crystalline mesophases with different 3-dimensional structures.
55
 Mesophases are 
thermodynamically distinct phases between a low-temperature solid phase and a high-
temperature isotropic liquid phase and are formed as a result of either repulsive or 
attractive inter-micelle interactions.
55-56
  Mesophases that result from repulsive inter-
micelle interactions are typically single liquid crystalline phases that fill an entire sample 
volume, while mesophases that result from attractive inter-micelle interactions phase 
separate and are found within two-phase systems.
56
  An example of a mesophase is the 
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hexagonal array of rod-like micelles observed with concentrated aqueous solutions of 
cetyltrimethylammonium bromide (CTAB).  The self-assembly of the micelles in the 
CTAB/H2O mesophase is governed by long-range repulsive interactions between 
individual micelles.  The micelles arrange in a manner in which inter-micelle spacing is 
maximized, thereby creating a single liquid crystalline mesophase throughout the sample 
volume and minimizing the Gibbs free energy of the system.
56
  
Though a wide variety of mesophase structures have been reported, the most 
common are lamellar, hexagonal, and cubic.
 55, 57
  The structure of the mesophase is 
dependent upon the physical properties of the surfactant and can be defined by the local 
effective surfactant packing parameter, g , where g = V/a01, and V is the total volume of 
the surfactant chains including any cosolvent molecules incorporated between the chains, 
a0 is the effective head group area at the micelle surface, and 1 is the kinetic surfactant 
tail length or the curvature elastic energy.
 55-57
  Mesophase morphology is also highly 
dependent on the concentration of the surfactant, pressure, temperature, and co-solvents 
or additives.
 55
   
Stuckey and coworkers have shown that the addition of a silica precursor to a 
micellar cationic surfactant solution under aqueous alkaline conditions results in the 
formation of surfactant-silicate mesophases.  Stucky et. al. hypothesize that the formation 
of mesophase assemblies at surfactant concentrations lower than typically observed is 
due to the presence of anionic silicate species formed from the hydrolysis of the silica 
precursor under the basic reaction conditions.
 56
  The multivalent, anionic silicate species 
associate with the cationic head groups of the surfactant on the surface of preformed 
micelles and  mediate the assembly of the micelles into liquid crystalline mesophases by 
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increasing attractive inter-micelle interactions.
 56
  Stucky states that the increased 
attractive interactions between micelles results in micellar aggregation and phase 
separation, “whereby one or more concentrated silicate-surfactant-rich phases adopt 
morphologies that minimize the total Gibbs free energy…”
56
  
As an example of surfactant-silicate mesophase formation followed by templated 
silicate polymerization, consider the mechanism of MCM-41 silica formation, which is 
outlined in Figure 17.  MCM-41 is prepared using cetyltrimethylammonium bromide 
(CTAB) as the surfactant and a silica precursor, such as tetraethyl orthosilicate (TEOS), 
under aqueous alkaline conditions.  The sequence of events leading to the formation of 
MCM-41 silica material is as follows:  (1) CTAB molecules self-assemble into rod-like 
micelles.  (2) Under basic conditions, the silica precursor is hydrolyzed, forming silicate 
anions.  (3) Silicate anions displace the bromide ions associated with the positively 
charge ammonium ions on the surface of the CTAB micelles and facilitate the formation 
of hexagonal surfactant-silicate mesophases.  (4) Silicate polymerization occurs on the 
surface and between the hexagonally arrayed micelles resulting in surfactant mesophases 
encased in a silica matrix.  (5) Removal of the surfactant via calcination or chemical 






















Due to the fact that silicate polymerization is template by the surfactant-silicate 
mesophase, the structure of the mesophase dictates the pore morphology of the resulting 
mesoporous silica.  Stucky and coworkers have demonstrated how the choice of 
surfactant and reaction conditions (specifically temperature, reaction time, and pH) 
determine the pore architecture of mesoporous silica materials.
57
  Table 4 lists common 
mesoporous silica systems with their mesophase structure and the surfactant used to 






Table 4:  Mesoporous silica materials 
Silica Type Surfactant Solvent / Base or Acid Mesophase Structure Reference 
MCM-41 C16H33(CH3)3 N
+
 H20 / NaOH 2D hexagonal p6m 1 
 C16-6-16
a
 H20 / NaOH  57 
MCM-48 C16H33(CH3)3 N
+
 H20, EtOH / NH4OH Cubic Ia3d 58 
 C22-12-22
a





H20 / HCl Cubic Pm3n 57 
SBA-2 C16-2-1
b
 H20 / NaOH 3D hexagonal P63/mmc 57 
SBA-15 EO20PO70EO20
c 
H20 / HCl 2D hexagonal p6mm 54 
SBA-16 EO106PO70EO106
d 
H20 / HCl Cubic Im3m 54 
a:  A “Gemini surfactant”.  A synthetic amphiphile with the general formula Cm-s-m that contains, in 
sequence, a hydrophobic chain of length, m, an ionic group, a spacer group of length, s, an ionic group, and 
a hydrophobic chain of length, m.  b:  A “divalent surfactant”.  A synthetic amphiphile with the general 
formula Cn-s-l that contains a hydrophilic chain of length, n, an ionic group, a spacer of length, s, and a 




1.2 Mesoporous Silica Nanoparticles 
In their seminal 1968 publication, Stöber and colleagues describe the preparation 
of solid silica spheres of uniform size using alkyl-siloxanes and ammonium hydroxide in 
alcohol/water mixtures.
59
  Particle sizes can be controlled by the choice of alcohol and 
range from 50 nm to 2 µm.  This method for creating monodispersed, sub-micron sized 
silica particles is now widely known as the “Stöber method”. 
Materials now known as mesoporous silica nanoparticles (MSN) were first 
reported by Unger.
60
  Unger et al. incorporated silica mesopore formation principles into 
the Stöber method.  Introducing cetyltrimethylammonium bromide (CTAB) into Stöber’s 
general synthetic procedure yielded spherical silica particles having diameters ranging 
from 400 nm to 1 µm and containing pore structures similar to that of MCM-41.
60
  Since 
that time, researchers have modified and refined this strategy to create MSN systems with 
controlled particle size and monodispersity.
61-63
  However, both Cui and Lin have 
demonstrated that mesoporous silica nanoparticles can be prepared from classic MCM-41 




  In addition, Imai and coworkers
65
 have prepared nano-sized, 





 have employed aerosol techniques to prepare MSN.
 
 
1.3 MSN as Controlled Release, Drug Delivery Systems 
Site-specific, controlled-release drug delivery systems are highly sought after due 
to their potential to increase the efficiency and reduce the side effects of systemic 
chemotherapy. Conceptually, the goal of a site-specific, controlled-release drug delivery 
system is to carry a payload of chemotherapeutics directly to a pre-selected type of 
cancerous tissue.  Once the loaded, drug delivery system has reached the tumor, release 
of the chemotherapeutic payload from the device is triggered. Thus, drug delivery 
systems would increase the amount of drug that reaches the tumor and reduce the 
collateral damage of the drug to healthy tissue and cells.  Mesoporous silica nanoparticles 
(MSN) have emerged as material well suited for site-specific, controlled-release drug 
delivery systems due to their high surface area and large payload capacity, ease of surface 
modification/functionalization, and biocompatibility.69 
Vallet-Regi and coworkers were the first to study MCM-41 material as drug 
delivery systems and proved that MCM-41 could be used to absorb and then later release 
ibuprofen.
8









, as well as 
the chemical characteristics of the loaded analyte
18-19
 affect both the absorption and 









 between the entrapped molecules and the silica surface affect the rate of release 
from these porous materials.  Recently, Ng et al. used confocal laser scanning microscopy 
to show that cationic molecules have a different release profile than anionic molecules 
from mesoporous silica spheres due to the affinity between the cationic molecules and the 
negatively charged silica surface.
 19  
 
While the above systems utilize pore size and electrostatic interactions for 
controlled release, others have developed more complex systems in which stimuli 
responsive capping agents, supramolecular assemblies, or polymers are employed to 
control the release of guest molecules.  Fujiwara demonstrated the potential of stimuli 
responsive controlled release devices by controlling the uptake and release of guest 
molecules into and out of coumarin-functionalized MCM-41 using UV radiation.
26
  Lin 
and coworkers have designed several systems in which CdS or gold nanoparticles are 
used to “cap” loaded MSN.  The nanoparticles can be removed from the surface of the 
MSN upon the addition of a reducing agent or by irradiating the system with 365 nm 
light.
6-7, 20-22
  More recently, Zhu and Guo have developed a pH-sensitive drug delivery 
systems by using acid sensitive zinc oxide quantum dots to seal the pores of drug-loaded 
MSN.
44
  Zink and Stoddart have made controlled release systems from mesoporous silica 







. Kim has also reported a gated-release system utilizing a 
pH responsive supramolecular motif on the MSN surface.
35





 have reported temperature-controlled release devices utilizing a surface bound 




 have created systems in which 
release is governed by a pH responsive polymer.  Similarly, Lin et al. designed insulin 
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loaded MSN that are sealed with glucose responsive proteins.
23
  And, very recently, 
Wang
37
 coated the surface of MSN with polyelectrolyte multilayers to obtain a controlled 
release system that is responsive toward reducing agents, while Liu and coworkers
46
 used 




2 Results and Discussion 
It is established that MSN can be taken into a cell through endocytosis.
7, 69 
 The 
pH inside an endosome is lower than cytosolic environment in a cell.
70
  Thus, one can 
anticipate that a release strategy that employs pH as a trigger for release would be 
particularly attractive.
 32, 44-51
  Ultimately, our goal is to create a MSN drug delivery 
system that shows no release at physiological pH (7.4) and fast release at pH 5, the 
typical pH within an endosome (Figure 18).  This type of delivery system would ensure 
that the entrapped drug would be released from the nanoparticle only after the 
nanoparticle has been endocytosed into the target tissue.  Herein, we report on our initial 
steps toward such a system and the work that has been done to maximize the loading 
efficiency of mesoporous silica nanoparticles and to better understand how surface 










2.1 Characterization of MSN 
To ensure the presence of colloidal material would not interfere with measuring 
the UV-Vis absorbance of the supernatant during the kinetic release studies, a gravity 
filtration technique (described above) was employed to obtain MSN of appropriate size.  
The larger particles comprising the retentate after the final filtration cycle were used in 
the kinetic release studies because they can be quickly and easily separated from the 
supernatant via centrifugation.  Dynamic light scattering showed that the MSN used in 
the kinetic release studies had an average diameter of 1.6 !m.  Though the particles are 
micron-sized, we propose that they are an appropriate model for nano-scale systems since 
the pore morphologies of nano- and micron-sized particles are identical.  Figure 19 




Figure 19:  TEM images of MSN used in release studies.  The figure on the right shows 
the porous character of the particles. 
                   
 
To quantify the porous nature of the particles, BET gas sorptometry was 
conducted.  The surface area of the particles was measured to be 206.88 m2/g.  Though 
the BET surface area of our MSN is less than other MSN materials1-3, 8, 20, the 
adsorption/desorption isotherms (Figure 20) are indicative of typical mesoporous 
systems, having type IV physisorption isotherms with H2 hysteresis.  The H2 hysteresis 
and the forced closure of the hysteresis loop indicate random pore distribution and an 
interconnected pore system.71  The cumulative volume of the pores was calculated to be 
0.42 cm3/g, and the average pore width was calculated as 86.12 Å.  The cumulative pore 
volume and average pore width were calculated using the BJH model from the adsorption 









The zeta potentials of non-coated (bare) and APTES-coated MSN were measured 
at pH 7.4 and 5.0 in buffer solution having an ionic strength (I) of 0.16 M to quantify the 
surface charge of the particles under the release conditions.  The zeta potential 
measurement results are shown in Table 5.  As expected, the amine-functionalized MSN 
have positive potentials, while the bare MSN have negative potentials.  In addition, the 
APTES-coated particles have a greater positive potential, and the bare MSN have a 
smaller negative potential at pH 5.0 than at pH 7.4, which was anticipated due to the 
increased acidity of the solution.  It should be noted that the zeta potential measurements 
for the bare MSN at pH 5.0 were not reproducible (12 trials were required to obtain three 
measurements that were of good quality) which can be attributed to the fact that the 
particles were near their point of zero-charge.   
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Table 5 : Zeta potential measurements of APTES-coated and bare MSN at pH 7.4 and 
5.0. 
MSN Type pH Zeta Potential (STD), mV 
Bare 7.4 -25.5 (1.2) 
Bare 5.0 -3.4 (0.5) 
APTES-coated 7.4 +12.2 (2.2) 
APTES-coated 5.0 +41.1 (1.0) 
 
 
2.2 Loading and Release Studies 
In the course of our studies, we discovered that the MSN must be sonicated in dye 
solution to maximize loading.  Figure 21 shows the difference in release profiles of 
rhodamine 6G (R6G) from MSN that were sonicated in dye solution versus MSN that 
were only allowed to soak in dye solution and were not sonicated.  (All loading 
conditions were identical except for sonication, and the releases were conducted in PBS 
buffer at 25 
o
C). The results clearly indicate that sonication increases the amount of dye 
that is loaded into the MSN; simply letting the particles soak in dye solution does not 
optimize their loading capacity.  MSN that were sonicated in dye solution released ~4.5 
µg of R6G per mg of MSN more than MSN that were not sonicated. 
Analysis of the release profiles from sonicated and unsonicated MSN revealed an 
interesting phenomenon.  The release of R6G from unsonicated bare MSN at pH 7.4 was 
best modeled by single exponential function (Eq. 3).  The release from sonicated bare 
MSN, however, was best fit by the double exponential function (Eq. 1).  The parameters 
for each function are given in Table 6.  The double exponential release seen from 
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sonicated MSN is attributed to two different diffusion processes which are discussed in 
more detail below.
19
  We propose that the sonication process enables R6G to penetrate 
completely into the center of the MSN (Figure 21) which results in a biphasic release 
pattern.  Conversely, we believe that unsonicated MSN have R6G bound only to the 
exterior surface (Figure 22) and thus show a single diffusion process that fits a single 
exponential function. 
 
Figure 21 :  Release profiles of rhodamine 6G from MSN with and without sonication.  
 
The data points for release of R6G from MSN with sonication are an average of three trials with standard 
deviation shown.  The data points for release of R6G from MSN without sonication are from a single trial.  





Table 6: Fit parameters for release of rhodamine 6G from sonicated and unsonicated 









































Yes 6.78(12) 48(15) 1.0(4) 0.14(6) 0.69(17) 4.9(15) 3.5(10) 3.3(10) 
No 2.16(2) --- 1.21(8) --- 0.58(3) --- --- --- 
a
In parentheses is the estimated standard error of the fit on the last significant digit(s). 
b





Figure 22 :  Schematic representation of the effect of sonication on MSN loading.  A:  










After determining how to maximize the MSN’s loading capabilities, we studied 
the effect of pH on release kinetics.  Figure 23 compares the release of rhodamine 6G 
from unmodified MSN at pH 5.0 and pH 7.4.  At both pH values, there is an initial burst 
of release within the first 3 hours followed by a slower release period that levels off after 
about 40 hours.  This result is similar to release from other reported MSN systems.
8-14, 19
  
The rate and amount of release at pH 5.0 is much greater than at pH 7.4 for uncoated 
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MSN.  At pH 5.0, the uncoated particles released 3 !g of rhodamine 6G more per mg of 
MSN than at pH 7.4 (~10.0 µg of rhodamine 6G per mg of MSN at pH 5.0 versus ~7.0 
µg of rhodamine 6G per mg of MSN at pH 7.4).  These results are consistent with the 
findings of Tang et al., where the release rate of famotidine from carboxylic acid 
modified MSU increased in acidic gastric medium.
12
  The increase in rate and amount 
released can be attributed to decreased electrostatic interactions between the positively 
charged rhodamine 6G molecules and the silica surface at pH 5.0 (Figure 24).  At pH 7.4, 
the surface of MSN has a greater negative charge than at pH 5.0, as indicated by the zeta 
potentials of the particles.  At pH 7.4, the particles have a zeta potential of -25.5 mV, 
while at pH 5.0, the MSN have a zeta potential of -3.40 mV (Table 5).  The difference in 
zeta potential is attributed to the protonation of negatively charged silanol groups on the 











Figure 23 :  Release profiles of rhodamine 6G from bare MSN at pH 7.4 and 5.0.   
 
The data points are an average of three trials with standard deviation shown.  The release profiles were fit 












Figure 24 :  Schematic representation of release of rhodamine 6G from bare MSN at pH 


















Release at pH = 7.4


































Both of the release profiles from the bare MSN, at pH 5.0 and pH 7.4, were better 
modeled by a two-phase (double) exponential function (see experimental; eq. 1).  The fit 
parameters for release from bare MSN at pH 7.4 and pH 5.0 are shown in Table 7.  From 
the fit parameters, the half-life and span of each phase were calculated (Table 7). 
 
 





































5.0 9.97(7) 29(2) 2.3(2) 0.12(2) 0.30(2) 5.6(6) 7.1(2) 2.9(2) 
7.4 6.78(12) 48(15) 1.0(4) 0.14(6) 0.69(17) 4.9(15) 3.5(10) 3.3(10) 
a
In parentheses is the estimated standard error of the fit on the last significant digit(s). 
b




These results are consistent with the findings of Ng et al.
19
  Using confocal laser 
scanning microscopy (CLSM), Ng et al. monitored the release of rhodamine 6G from 
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mesoporous silica microspheres.  It was found that the release of rhodamine 6G from 
bare mesoporous silica microspheres was biphasic and could not be described as a simple 
diffusion process.
19
  The authors reported an initial fast release period, which was 
followed by a second slow release period.  The initial rapid release phase is attributed to 
the release of dye molecules located near the exterior of the mesoporous spheres, while 
the slower release period is attributed to the release of dye molecules that were initially 
located near the center of the particles. Using CLSM, it was observed that a layer of 
surface adsorbed R6G molecules formed near the exterior of the mesoporous particles.  It 
is hypothesized that this layer of adsorbed R6G reduced the effective pore size of the 
particles and inhibited the escape of R6G molecules initially located near the center of the 




Having demonstrated the effect of pH on release from MSN with anionic 
surfaces, we were interested in seeing how pH affects release from MSN with cationic 
surfaces.  Therefore, we modified the surface of MSN with (3-
aminopropyl)triethoxysilane (APTES).  Figure 25 depicts the release profile of 
rhodamine 6G from APTES-coated MSN at pH 7.4 and pH 5.0.  Though the release 
profile at pH 7.4 from the amine-coated MSN appears to be similar to the release profile 
of uncoated MSN at the same pH, there is an initial lag period seen during the first 90 
minutes.  Clearly, release from APTES-coated MSN at pH 5.0 is much different than the 
other release profiles:  there is initially a slow release period seen during the first four 
hours, which is followed by a faster release phase that begins to level off after about 20 
hours (Figure 25).  Casasus et al. have reported similar release profiles of a ruthenium 
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dye from polyamine coated MCM-41 at pH 4.0.
13
  However, their analogues 3-
aminopropyl functionalized system did not exhibit the same delayed release profile.
13
  
This difference may be associated with the method used to functionalize the surface of 
the MSN with APTES.  Casasus functionalized MSN with APTES under anhydrous 
conditions, while we silanized our MSN in PBS solution.  It is documented that water 
promotes multilayer formation and better surface coverage during the silanization of 
silica.
72-74
  As with the uncoated particles, more total release is seen at pH 5.0 than at 7.4 
for the amine coated-MSN.  Approximately 7.5 µg of R6G was released per mg of MSN 
at pH 5.0, while about 6.0 µg of R6G was released per mg of MSN at pH 7.4 (Figure 25).  
The initial lag period seen at pH 7.4 and the unique release profile at pH 5.0 seen for the 
amine-coated MSN can be rationalized by considering the surface coverage and charge of 
these particles.  We hypothesize that the repulsive interaction between the positively 
charged amine groups and cationic rhodamine 6G molecules inhibit the escape of 
entrapped R6G molecules within the MSN matrix (Figure 26).  At pH 7.4, protonated 
amine groups and negatively charged silanol groups create a zwitterionic surface on 
amine-functionalized MSN.  Based upon the positive zeta potential (+12.2 mV) we 
assume that there are more protonated amine groups than negatively charged silanol 
moieties.  However, at pH 5.0, the surfaces of the MSN have a greater positive charge 
(+41.1 mV) due to the neutralization of the silanol groups.  The increased positive surface 
charge of the amine-coated MSN can account for the more significant lag period 
observed at pH 5.0.  It should be noted that the basic rhodamine 6G molecules are 
expected to be protonated and positively charged under both pH conditions.  Molecular 
modeling reported by Casasus et al. suggest that amine monolayers will expand under 
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acidic conditions due to coulombic repulsion between adjacent protonated amine groups.
 
13
  This expanded monolayer will decrease the effective diameter of the pore openings of 
the MSN and thereby hinder the ability of rhodamine 6G molecules to escape from the 
MSN matrix.  Thus, the decreased dimensions of the pore openings and repulsive 
interaction between rhodamine 6G and the protonated amine groups located on the 
surface of the MSN could be the cause of the lag seen at pH 7.4 and the diminished 
release rate seen at pH 5.0 for these amine-coated MSN. 
 
Figure 25:  Release profiles of rhodamine 6G from amine-coated MSN at pH 7.4 and 5.0.   
 
The data points are an average of three trials with standard deviation shown.  The release profiles were fit 




Figure 26 :  Schematic representation of release of rhodamine 6G from APTES-coated 




Interestingly, both of the release profiles from the APTES-functionalized MSN, at 
pH 5.0 and pH 7.4, were better modeled by the single-phase exponential (see 
experimental; eq. 3).  The fit parameters and calculated half-life are shown in Table 8. 
 
Table 8: One-phase fit parameters and half-life for release of rhodamine 6G from 
APTES-coated MSN. 
pH 









5.0 8.46(15) 0.050(2) 13.9(4) 
7.4 6.19(5) 0.23(1) 3.06(6) 
a
In parentheses is the estimated standard error of the fit on the last significant digit(s). 
b
In parentheses is the standard error estimated from the error of the fit on the last significant digit(s). 
 
! 72 
The single-phase release kinetics from APTES-functionalized MSN can be 
explained by considering the effect of the amine coating on the release of rhodamine 6G 
molecules from the MSN.
 
 As stated above, Ng hypothesizes that the slow second release 
phase observed from bare mesoporous silica particles was due to a layer of adsorbed 
rhodamine 6G molecules near the exterior of the particles, which inhibited the escape of 
rhodamine 6G molecules initially located near the center of the particle.
19
  We reason that 
the APTES coating on the surface of the MSN also acted as a barrier to dye molecules 
escaping from within the MSN.  However, we hypothesize that the APTES coating was a 
more significant barrier to release and reduced the rate of release to a greater extent than 
the proposed layer of adsorbed rhodamine 6G molecules near the exterior of the MSN.   
In addition, unlike the adsorbed R6G layer, the amine coating also inhibited the release of 
R6G molecules initially located near the exterior of the particles.  Therefore, the rate of 
release from APTES-functionalized MSN was dependent on the ability of R6G molecules 
to diffuse through the amine coating.  We theorize that release from APTES-
functionalized MSN was defined as a single diffusion process due to the fact that all 
escaping molecules had to navigate through the APTES coating, regardless if the 
molecules were initially located near the exterior or the center of the MSN. 
!
!
3 Conclusions  
The loading and release of rhodamine 6G from unmodified and amine-coated 
MSN has been studied and the features of this release have been measured.  It was found 
that sonication of MSN in dye solution was necessary to maximize the loading capacity 
of the particles.  It was also determined that both surface modification and pH affect the 
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rate and amount of release from MSN, which is governed by coulombic interactions.  
Release from bare MSN at both pH 7.4 and pH 5.0 followed the same general pattern—
an initial burst of release followed by a slower, delayed release period.  The increased 
release from the uncoated MSN at pH 5.0 is attributed to decreased electrostatic 
interactions between the silica surface and entrapped rhodamine 6G molecules.  The 
initial lag period seen for the amine-coated MSN at pH 7.4 and the unique release profile 
seen for the same particles at pH 5.0 can be explained by repulsive interactions between 
protonated amine groups on the exterior surface of the MSN and rhodamine 6G 
molecules.  Release profiles from APTES-coated MSN better fit a single exponential 
function while release profiles from bare MSN better fit a double exponential function—




All materials were used as received from the supplier.  Rhodamine 6G (R6G) was 
obtained from Sigma Aldrich (BioChemika, for fluorescence:  83697). (3-
Aminopropyl)triethoxysilane (APTES) was obtained from Sigma Aldrich (Fluka:  
09324).  Tetraethyl orthosilicate was obtained from Sigma Aldrich.  Pluronic® F-127 
was obtain from BASF.  All aqueous solutions were made using water filtered through a 
Millipore water filtration system unless otherwise indicated.  Phosphate buffered saline 
(PBS) solutions were prepared from phosphate buffered saline tablets obtained from 
Sigma Aldrich (Sigma, tablets:  P4417) as directed.   The PBS solutions prepared had a 
measured pH of 7.4 and an ionic strength of 0.16 M.  Acetic acid (0.78 mL, 13.63 mmol) 
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and sodium acetate (2.88 g, 35.11 mmol) used to prepare the acetate buffer (400 mL, pH 
= 5.0) were obtained from J.T. Baker.  An Ocean Optics USB 2000 Spectrometer was 
used to measure the absorbance (A) of the supernatant during release studies.  A 
Bransonic 321 desk sonicator was used to sonicate MSN samples.  Zeta potentials were 
measured using a Zetasizer Nano ZS90 from Malvern Instruments Ltd.  BET and BJH 
measurements were obtained using a Micromeritics Tristar II 3020 Surface Area 
Analyzer.  The surface area of standard silica-alumina pellets received from 
Micromeritics was measured to verify the instrument was in proper working condition.  
 
4.2 Fabrication of MSN   
MSN were prepared in the Zachariah lab in the Department of Chemistry at the 
University of Maryland, College Park.  MSN were fabricated by a template-assisted sol-
gel process that was implemented via aerosol technique. Aerosol droplets were created 
from a stainless steel pressure atomizer containing the precursor mixing solution 
consisting of tetraethyl orthosilicate (2.6 g, 13 mmol) and Pluronic® F-127 (0.55 g, 0.04 
mmol) dissolved in absolute ethanol (17.3 mL) and deionized water (9.0 mL) adjusted to 
pH = 1.2 with HCl.  Droplets being carried through a stainless steal tube by dried air 
passed through a diffusion-dryer to remove most of the solvent and then through a tube 
furnace at 400 
o
C.  Normal residence time was 1 second under the gas flow rate of 3.5 
L/min used in the experiments.  Particles were collected on a 0.2 µm pore Millipore 
HTTP membrane filter housed in a stainless steel holder (covered by heating tape to 
prevent re-condensation of solvent vapor).  After being removed from the membrane, 
particles were calcined at 500 
o
C for 4 h to remove the surfactant and yield MSN.  
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4.3 Gravity Filtration  
A 2.0 mg/mL stock suspension of MSN in Millipore water was made, vortexed, 
and then sonicated using a Bransonic 321 desk sonicator for 30 minutes.  The suspension 
was then allowed to settle for 24 hours. The upper 45 mL of supernatant was removed by 
pipette and the remaining retentate was diluted back to 50 mL using fresh Millipore 
water.  The suspension was vortexed and then sonicated for 30 minutes.  This procedure 
was repeated three (3) times.  The particles remaining after the fourth cycle were dried in 
vacuo and were used in the release studies. 
 
4.4 Rhodamine 6G Loading   
The MSN comprising the retentate (dried) remaining after the gravity filtration 
process were added to a 0.15 mg/mL solution of rhodamine 6G in PBS buffer to make a 2 
mg/mL suspension of MSN in rhodamine 6G solution.  The suspension was vortexed and 
then sat undisturbed for 48 hours.  The particles were sonicated in the 0.15 mg/mL 
rhodamine 6G solution where indicated. 
 
4.5 MSN Functionalization  
An aliquot of the MSN / rhodamine 6G suspension was removed from the stock 
solution and sonicated for 30 minutes.  3-Aminopropyl triethoxy silane (APTES) was 
added to the aliquot to yield a 0.1 mL APTES / mg MSN solution.  The reaction mixture 
stirred at room temperature for 10 minutes and was then centrifuged.  The supernatant 
was removed.  The functionalized MSN were immediately used in a release experiment. 
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4.6 Rhodamine 6G Release Quantification using UV-Vis Spectroscopy 
An aliquot of the MSN / rhodamine 6G suspension (5.0 mL) was removed from 
the stock solution and sonicated for 30 minutes.  The sample suspension was then 
centrifuged and the supernatant was removed by pipette.  The particles were washed with 
PBS buffer (5.0 mL) and centrifuged for 5 minutes.  The supernatant was removed via 
pipette.  The washing process was repeated twice more.  After the final washing process, 
the MSN were resuspended in buffer solution at the desired pH and 25 
o
C.  PBS buffer 
was used for release at pH 7.4, while acetate buffer was used for release at pH 5.0.  A 2.0 
mL aliquot was removed from the suspension and centrifuged.  The absorbance of the 
supernatant was measured using an Ocean Optics USB 2000 Spectrometer.  The analyzed 
supernatant and the 2.0 mL aliquot were then returned to the sample suspension.  This 
process was repeated every twenty minutes until no further release was observed. 
 
4.7 Mathematical Modeling of Release from MSN 
For each release profile, GraphPad Prism was used to perform nonlinear least 
squares fitting to both a double exponential and a single exponential function, and the 
best fit model was chosen using the Extra Sum-of-Squares F test. 
The double exponential function, which describes two processes that have rates 
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where S1 is the amount released during the first phase and S2 is the amount released 
during the second phase, k1 is the rate constant of the first phase, k2 is the rate constant of 

















where P is the total amount released and F2 is the percent of  release that occurs in the 
second phase. 
The single-phase exponential function is defined as: 
 
! 
M = P(1" e
"kt
) (3) 
where P is the total amount released and k is the rate constant. 
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Chapter 3:  MSN-Based Fluorescent Silica Nanoparticles for Application in 
Diagnostics 
 
1 Introduction       
 Fluorescent silica nanoparticles (FSN) have recently gained attention for their 





, and detect pathogens
3-6
.  Fluorescent silica 
nanoparticles are particularly attractive for these applications because they can be 
prepared in a wide variety of colors, have strong, stable fluorescence, and are 
biocompatible.
7-12
  Importantly, these characteristics give FSN distinct advantages over 
quantum dot systems, which are often used for similar applications, but are hindered by 
cytotoxicity and unstable fluorescence.
13-15
 
Preparing fluorescent silica nanoparticles suitable for use in diagnostics poses 
several challenges.  Unlike metallic quantum dots, which have intrinsic fluorescent 
properties, the fluorescent character of fluorescent silica nanoparticles is derived from 
dye molecules incorporated into the silica matrix.  Therefore, measures need to be taken 
to ensure that the dye molecules remain within the silica matrix and do not leach from the 
particles.  In addition, to obtain particles that reproducibly exhibit the same function from 
batch to batch, the method used to prepare the FSN must yield particles that are uniform 
and monodisperse.  For use in diagnostic applications, FSN are functionalized with 
biomolecules, such as protein and carbohydrates, which serve as recognition or receptor 
moieties.  However, biomolecules that are nonspecifically (passively) bound to surfaces 
through electrostatic or hydrophobic interactions often lose their biological function.  
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Thus, a strategy to selectively, controllably, and covalently attach a biomolecule to the 
surface is needed.  This chapter presents the work accomplished within the DeShong lab 
to overcome these challenges and prepare fluorescent silica nanoparticles for application 
in flow cytometry and solid-phase immunoassays.    
 
1.1 Fluorescent Silica Nanoparticle Synthesis 
 Fluorescent silica nanoparticles are typically prepared in one of two ways: (1) 
incorporation of siloxane-functionalized dyes into typical sol gel silica nanoparticle 
synthesis
4, 6, 11, 13, 16-27 
(Figure 27, A), or (2) entrapment of dyes into silica nanoparticles 
prepared via microemulsion techniques
5, 7-10, 12, 28-37 
(Figure 27, B).  In the first method, 
the siloxane-functionalized dye is hydrolyzed to a silicate derivative, undergoes 
polymerization with other silicate anions in solution, and becomes covalently 
incorporated into the silica framework of the nanoparticles.  Others have expanded this 
methodology to create analogous fluorescent mesoporous silica nanoparticles.
38-41
  The  
second method is illustrated in Figure 29, B.
42
  The components of the reaction mixture 
generate a water in oil microemulsion.  Silicate anions (from the hydrolysis of TEOS) 
and hydrophilic dye molecules reside within the aqueous phase of the microemulsion.  As 
silicate polymerization occurs within the aqueous phase, the dye molecules become 




Figure 27:  Common strategies used to prepare fluorescent silica nanoparticles:  (A)  
Incorporation of siloxane-functionalized dye molecules into the sol-gel preparation of 































2 Results and Discussion 
2.1 MSN-Based FSN Synthesis 
While studying the release of rhodamine 6G from mesoporous silica nanoparticles 
(discussed in chapter 2 of this dissertation), it was observed that dye-loaded MSN, 
prepared via wet-impregnation, were exceptionally bright, but released dye over time.  
Having the ability to contain the dye within the particles would result in strongly 
fluorescent materials with potential diagnostic applications.  Notably, Rocha et al. report 
preparing non-leachable fluorescent silica nanoparticles by loading MSN with dye via 
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impregnation and then entrapping the dye with a silica coating.
43  
However, through the 
understanding of mesoporous silica nanoparticle formation, we rationalized that 
incorporating hydrophobically modified dye into mesoporous silica nanoparticle 
synthesis would be a facile, one-step method to produce highly fluorescent silica 
nanoparticles that would not leach dye. 
As discussed in chapter 2 of this dissertation, mesoporous silica nanoparticles 
(MSN) are synthesized by the templated polymerization of silicate around a surfactant 
mesophase.
44-45
  The surfactant within the as-synthesized MSN is then removed via 
calcination or chemical extraction, yielding mesoporous silica nanoparticles.  Figure 28 
illustrates MCM-41 type MSN synthesis.
44-45
  We hypothesized that a hydrophobically 
modified dye would become incorporated into the surfactant-silicate mesophase and then 
become entrapped within the silica matrix of the as-synthesized MSN, resulting in 
fluorescent silica nanoparticles (Figure 29).  The fluorescent, as-synthesized MSN would 
not be calcined and hydrophobic interactions between the hydrophobically modified dye 
and the interior of the surfactant mesophase would secure the dye within the particle.  
Thus, we introduced fatty acid modified rhodamine B, 1  (Figure 30), into the MSN 
synthesis protocol described by Okuyama.
46
  The particles produced from this 
methodology are fluorescent, spherical and approximately 100 nm in diameter.  Figure 31 
depicts TEM images of the prepared FSN.  It should be noted that Imai et al. report 
making FSN by incorporating dye molecules into their binary surfactant MSN synthetic 
methodology.
47
  The authors theorize that dye is incorporated into the hydrophobic core 


























































Figure 31:  TEM images of prepared MSN-based FSN. 
 
    
 
 With fluorescent silica nanoparticles in hand, studies were conducted to examine 
the feasibility of using these materials in diagnostic applications.  The goals of the 
following experiments were to (1) analyze the fluorescent character of the particles and 
determine how the hydrophobically modified dye is incorporated into the particles, (2) 
evaluate if any dye is leached from the particles under simulated physiological 
conditions, and (3) develop a strategy to selectively and covalently attach protein 
antibodies to the FSN surface, which would help ensure that the protein would retain its 
biological function after it is bound to the surface.  
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2.2 Fluorescence Microscopy Analysis of FSN 
 
 The fluorescent properties of the prepared fluorescent silica nanoparticles were 
analyzed using confocal microscopy.  Z-scan confocal imaging of the fluorescent silica 
nanoparticles indicates that the hydrophobically modified dye is incorporated and evenly 
distributed throughout the particles (Figure 32).  If the dye were only absorbed to the 
surface of the MSN, the Z-scan confocal images would appear as fluorescent rings, not as 
solid circles.  Figure 33 compares fluorescent intensity of the FSN with CdSe quantum 
dots.  Importantly, the fluorescent silica nanoparticles show strong, stable fluorescence 
that is approximately 5 times more intense than the fluorescence from CdSe quantum 
dots.  The breaks seen in the fluorescent image of the CdSe quantum dots are due to 
“blinking” phenomena typical of quantum dots.  
 
Figure 32:  Fluorescent, z-scan confocal images of MSN-based FSN.  The focus of the 
microscope was moved forward 1 micron in succession from a-h.  
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Figure 33:  Comparison of fluorescence intensity of MSN-based FSN and CdSe quantum 
dots. 
 
    FSN      CdSe quantum dot 
                              
 
2.3 Dye Release Experiments 
As mentioned above, Imai and coworkers prepared fluorescent silica particles by 
incorporating unmodified dyes into their MSN synthesis strategy.
47
  Though Imai et al. 
report that the resulting fluorescent particles retain their color and stay suspended in 
solution for a prolonged period of time, they do not state if any dye is leached from the 
particles.  For FSN to be suitable for in vitro and in vivo diagnostic applications, FSN 
cannot leach dye.  Prepared FSN were suspended in PBS buffer and the supernatant was 
analyzed using UV-vis spectroscopy.   It was found that no dye is released from the 
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fluorescent silica nanoparticles at 25 
o
C after 7 days, indicating that the FSN are stable 
enough to be used in diagnostic applications. 
 
2.4 Protein Functionalization of MSN-Based FSN 
For diagnostic applications, such as flow cytometry and solid phase-
immunoassays, the FSN were functionalized with protein antibodies.  As outlined in 
chapter 1 of this dissertation, there are a variety of methods commonly used to covalently 
attach proteins to surfaces.
48-49 
 Initially, the method described by Guo
50
 was followed to 
functionalize FSN with mouse anti-goat IgG.  Briefly, FSN were functionalized with 
GPTES to yield particles bearing surface epoxide moieties.   The epoxide functionalized 
FSN were then treated with mouse anti-goat IgG under high salt concentrations.  Binding 
of protein to FSN was verified using a standard bicinchoninic acid (BCA) colorimetric 
assay.
51-52
  An absorbance at 562 nm in the BCA assay indicates the presence of protein 
within the sample.  Figure 34 shows the absorbance spectra from the BCA assay of 
mouse anti-goat IgG functionalized FSN prepared using Guo’s method.  Epoxide –coated 
FSN were used as a control and a BSA solution (150 µg/mL) was used as an internal 
standard.  The results from the assay indicate that protein was successfully bound to the 






Figure 34:  Absorbance spectra from the BCA assay of mouse anti-goat IgG 
functionalized FSN prepared using Guo’s method.
50 
 
The absorance spectra shown are from a BCA assay of one trial.  Only one trial was performed. 
 
Having demonstrated that protein was bound to the FSN, the functionalized 
particles were tested for application in a solid-support immunoassay used to detect 
Neisseria gonorrhea.  Unfortunately, these efforts were unsuccessful.   Further studies 
revealed that, under the same reaction conditions, protein nonspecifically binds to bare 
(non-epoxide functionalized) FSN.  Due to the fact that nonspecifically bound proteins 
are known to lose their biological activity, we postulated that the failure of the IgG 
functionalized particles in the immunoassay was due to the protein nonspecifically 
binding and denaturing on the surface of the FSN.   Therefore, we set out to develop a 
strategy to selectively and controllably functionalize FSN with antibodies.  The 
development of this strategy required (1) the prevention of nonspecific binding, and (2) 
an easy and reliable way to covalently attach antibody proteins to the FSN surface. 
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To control the binding of antibodies to the FSN and help ensure that the 
antibodies retain their biological activity, nonspecific binding of antibodies to the FSN 
surface through hydrophobic and electrostatic interactions must be prevented.  It is well 
established that polyethylene glycol (PEG) derivatives can be used to prevent nonspecific 
binding of proteins to surfaces.
53-54
  Therefore, nonspecific binding of proteins was 
studied using PEGylated FSN, which were prepared by reacting bare FSN with 
PEGTMS.  Surprisingly, a significant amount of protein nonspecifically bound to 
PEGylated FSN.  However, it was found that the addition of PEG derivatives to the 
reaction mixture reduced nonspecific binding.  Figure 35 depicts the absorbance spectra 
from the BCA assay of PEGylated FSN treated with BSA with no PEG additive, with 
Tween 20, and with the triblock copolymer Pluronic F127 (EO106PO70EO106). The results 
from the assay show that BSA nonspecifically bound to PEGylated FSN when no PEG 
additive was used, and that Tween 20, a PEG polymer commonly used to prevent 
nonspecific binding, was not as effective as Pluronic F127 in preventing the nonspecific 
binding of BSA to PEGylated FSN (Figure 35).  Pluronic F127 also proved to be very 
effective in preventing the nonspecific binding of goat anti-listeria IgG, rabbit anti-goat 
IgG, and goat anti-gonococcus IgG antibodies to PEGylated FSN.  Figure 36 shows the 
results from the BCA assay of goat anti-listeria IgG antibody treated PEGylated FSN 
with and without Pluronic F127.  Similar results were seen with PEGylated FSN that 
have been treated with rabbit anti-goat IgG antibody, and PEGylated FSN that have been 




Figure 35:  Absorbance spectra from the BCA assay of BSA treated PEGylated FSN 
with no additional PEG additive (blue), Tween 20 (green), and Pluronic F127 (red).   
 





Figure 36:  Absorbance spectra from the BCA assay of goat anti-listeria IgG antibody 
treated PEGylated FSN with (red) and without (blue) Pluronic F127. 
 
The absorance spectra shown are from a BCA assay of one trial.  Only one trial was performed. 
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In developing a strategy to covalently attach protein to the FSN, we hypothesized 
that using a mixed multilayer system consisting of PEG and a reactive moiety would be 





  have successfully used such strategies to bind antibodies 
to silica surfaces.
 
Though several coupling methodologies were studied, it was found that 
immobilizing proteins to FSN functionalized with a mixed PEG/epoxide coating in the 
presence of Pluronic F127 was most efficient.
 
 Figure 37 depicts the functionalization 
strategy schematically.  It is hypothesized that PEGTMS and GPTES form a mixed-
multilayer on the silica surface as shown in figure 38.  PEG/epoxide functionalized 
particles that were exposed to goat anti-gonococcus IgG antibody, and then thoroughly 
washed with PBS buffer, tested positive for protein in the BCA assay—indicating that the 
antibody was successfully conjugated to the particles.  The absorbance spectrum from the 
BCA assay of these particles (referred to as IgG-functionalized particles) is shown in 
Figure 39 (green absorbance spectra).  PEG/epoxide functionalized FSN that were not 
exposed to antibody were used as a control in the BCA assay (Figure 39, red absorbance 
spectra).  As an additional control, PEG/epoxide functionalized particles were first 
pretreated with ethanolamine to deactivate the epoxide moieties, and then were exposed 
to goat anti-gonococcus IgG antibody.  BCA analysis indicates that less protein bound to 
the ethanolamine-pretreated PEG/epoxide particles than to PEG/epoxide particles that 
were not pretreated with ethanolamine (Figure 39, blue and green spectra, respectively).  
This result indicates that the protein was primarily immobilized onto the surface of the 
IgG-functionalized particles (non ethanolamine-pretreated particles) via covalent 
linkages.   From a standard curve generated from goat anti-gonococcus IgG antibody, it 
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was calculated that the protein concentration within the FSN sample was approximately 8 
µg of antibody per mg of FSN. 
 




































































Figure 39:  Absorbance spectra from the BCA assay of goat anti-gonococcus IgG 
antibody functionalized FSN (green), PEG/epoxide functionalized FSN (red; control), 
and ethanolamine pretreated PEG/epoxide FSN (blue; control). 
 
The absorance spectra shown are from a BCA assay of one trial.  The results are representative
 
of the 
results from three individual trials.  In each case, a stronger absorbance at 560 nm was observed for 
PEG/epoxide FSN that were not pretreated with ethanolamine and exposed to IgG antibody (referred to as 
IgG functionalized particles, green absorbance spectra) than for PEG/epoxide FSN that were pretreated 
with ethanolamine and then exposed to IgG antibody (referred to as ethanolamine pretreated particles, 





 Fluorescent silica nanoparticles were prepared by incorporating a hydrophobically 
modified dye into a mesoporous silica nanoparticle synthesis procedure.  The FSN do not 
leach dye and have strong, stable fluorescence that is 5 times more intense than that of 
quantum dots.  For diagnostic applications, a method to selectively and covalently bind 
antibodies to the surface of the FSN was devised.  It was found that the triblock 
copolymer, Pluronic F127, is effective in preventing nonspecific binding of proteins to 
FSN.  Antibodies were selectively and covalently attached to FSN that were 
functionalized with a mixed PEG/epoxide coating in the presence of F127.  The antibody-
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functionalized particles are now being tested for application in flow cytometry 
experiments by Stein and coworkers in the Department of Cell Biology and Molecular 





 All chemicals were used as received from the supplier.  2-
[Methoxy(polyethyleneoxy)propyl]trimethoxysiane (PEGTMS) and (3-
Glycidoxypropyl)trimethoxysilane (GPTES) were obtained from Gelest, Inc.  Tetraethyl 
orthosilicate (TEOS) was obtained from Sigma Aldrich.  Pluronic® F-127 was obtain 
from BASF.  All aqueous solutions were made using water filtered through a Millipore 
water filtration system unless otherwise indicated.  Phosphate buffered saline (PBS) 
solutions were prepared from phosphate buffered saline tablets obtained from Sigma 
Aldrich (Sigma, tablets:  P4417) as directed.   The PBS solutions prepared had a 
measured pH of 7.4.  The fatty acid modified rhodamine B dye, 1, [1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt)] 
was purchased from Advanti Polar Lipids, Inc.  An Ocean Optics USB 2000 
Spectrometer was used to obtain absorbance spectra.   Room temperature is defined as 20 
o
C.   
 
4.2 MSN-Based Fluorescent Silica Nanoparticle Preparation 
 Rhodamine dye, 1, [1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine 
rhodamine B sulfonyl) (ammonium salt)] (0.001 g) was transferred to a three-necked 
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round bottom flask in chloroform (1 mL) and dried in vacuo.  Water (15 ml) and 
cetyltrimethylammonium bromide (CTAB) (0.050 g) were added to the reaction vessel 
followed by 3 mL of an aqueous solution containing lysine
.
HCl (0.017 g) and NaHCO3 
(0.012 g)  The mixture was heated to 60 
o
C.  To the vigorously stirring, heated reaction 
mixture was added a mixture of TEOS (0.532 mL) in heptane (5.00 mL).  The 
TEOS/heptane mixture was added drop-wise in ten 0.5 mL aliquots.  The reaction 
mixture stirred at 60
o
C for 2h, giving rise to a red/pink precipitate.  The reaction mixture 
was cooled and transferred to a centrifuge tube.  The precipitate (FSN) was spun down 
and washed with PBS solution (10 mL) via centrifugation/resuspension three times and 
then dried in vacuo.   
 
4.3 Fluorescence Imaging 
 Dilute solutions of FSN in water were spin-coated onto glass slides.  The particles 
were excited with 488 nm wavelength light.  The images were acquired using 0.24 µW 
laser power with 5 ms dwell time per pixel.  Integrated intensities, Iave, were calculated 










4.4 PEG Functionalized FSN 
 FSN (0.010 g) were suspended in toluene (5.00 mL) and sonicated until evenly 
dispersed.  The solution was placed under an argon atmosphere. PEGTMS (0.610 mL, 1.3 
mmol) was added to the rapidly stirring solution in one aliquot.  The mixture stirred 
under argon atmosphere at room temperature for 2 hours.  The reaction mixture was 
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transferred to a centrifuge tube.  The functionalized particles were spun down and washed 
with toluene (5 mL) via centrifugation/resuspension three times and then dried in vacuo.   
 
4.5 PEG/Epoxide Functionalized FSN 
 FSN (0.010 g) were suspended in toluene (5.00 mL) and sonicated until evenly 
dispersed.  The solution was placed under an argon atmosphere.  PEGTMS (0.610 mL, 
1.3 mmol) was added to the rapidly stirring solution in one aliquot.  The mixture stirred 
under argon atmosphere at room temperature for 30 minutes.  An aliquot (0.100 mL) of a 
solution of GPTES (0.030 mL) in toluene (0.970 mL) (0.01 mmol of GPTES added) was 
then added to the reaction mixture.  The mixture continued to stir under argon 
atmosphere at room temperature for 1.5 hours.  The reaction mixture was transferred to a 
centrifuge tube.  The functionalized particles were spun down and washed with toluene (5 
mL) via centrifugation/resuspension three times and then dried in vacuo.   
 
4.6 Conjugation of Goat Anti-Gonococcus IgG Antibody to PEG/Epoxide 
Functionalized FSN 
 PEG/Epoxide functionalized FSN (0.005 g) were suspended in PBS solution (1.50 
mL).  An aliquot (0.150 mL) of a solution of Pluronic F127 in water (2 mg/mL) was 
added followed by 0.075 mL of a solution of goat anti-gonococcus IgG antibody in PBS 
(2 mg/mL).  The reaction mixture was sonicated until particles were evenly distributed, 
and then stirred at room temperature for 18 hours. The particles were spun down and 
washed with PBS (5 mL) via centrifugation/resuspension three times and then 
resuspensed in PBS (1 mL).  
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 As a control, PEG/Epoxide functionalized FSN were pretreated with 
ethanolamine to inactivate the epoxide moieties.  PEG/Epoxide functionalized FSN 
(0.005 g) were suspended in PBS solution (2.00 mL).  Ethanolamine (0.050 mL) was 
added and the reaction mixture was sonicated, and then stirred at room temperature for 3 
hours.  Afterward, the reaction mixture was incubated at 40 
o
C for 1 hour.  The particles 
were then spun down and washed with PBS (5 mL) via centrifugation/resuspension three 
times.  The pretreated particles were then exposed to goat anti-gonococcus IgG antibody 
in the same manner described above for the non-pretreated PEG/Epoxide functionalized 
particles. 
 
4.7 BCA Assay Protocol 
BCA assays were conducted using reagents from a Pierce BCA Protein Assay Kit 
purchased from Thermo Scientific.  The “Enhanced Test Tube Protocol” found in the 
instructions manual accompanying the BCA assay kit was employed.  Briefly, 0.100 mL 
of a 5 mg/mL suspension of particles in PBS solution was transferred to a 1 dram vial.  
2.00 mL of freshly prepared BCA “working reagent” was added to the vial.  The vial was 
capped and placed in a water bath set at 60 
o
C for 30 minutes.  Afterward, the vial was 
removed from the water bath and placed in a freezer for 10 minutes. The vial was 
removed from the freezer, allowed to warm to room temperature, and then the absorbance 
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